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Abstract 
 
The circadian timing system establishes daily rhythms in behavior and physiology throughout the 
body, ensuring that functions like activity, sleep and hormone release are appropriately timed.  Research 
suggests that his temporal synchrony within the body is quite important for health and survival.  In 
mammals, the central circadian pacemaker in the suprachiasmatic nucleus (SCN) drives rhythms in 
behavior and physiology in large part by stimulating or inhibiting other brain regions responsible for these 
functions at the appropriate times of day.  This timed signal is often indirect, i.e. relayed or possibly 
processed through a series of neurons in different brain regions before reaching the effector site.  The 
subparaventricular zone (SPZ), a region adjacent to the SCN which is the main recipient of direct 
neuronal inputs from the SCN, is thought to be a critical relay for SCN signals, since loss of the SPZ 
results in loss of circadian rhythms in body temperature, activity and sleep/wakefulness.  Another 
important relay site, the dorsomedial hypothalamic nucleus (DMH) gets direct input from both the SCN 
and SPZ and is critical for normal expression of various circadian rhythms. 
Both the SPZ and DMH have different subpopulations of neurons which may perform different 
functions with respect to circadian modulation of physiology and behavior, and which have not been well 
studied.  Chapter 2 of this dissertation focuses on the anatomical connectivity of four spatially defined 
subpopulations of cells in the SPZ, showing for the first time that they differ in density of their inputs to 
certain hypothalamic targets and that they project to each other as well as to the SCN. This chapter also 
reports several novel SPZ targets which may be important for the regulation of wakefulness.  Chapter 3 
examines the role of an excitatory subpopulation of DMH neurons by deleting a critical exon in the gene 
for a vesicular glutamate transporter, rendering these neurons unable to synaptically release glutamate.  
This manipulation blunts circadian rhythms in activity and urinary corticosterone, and decreases average 
body temperature and activity levels throughout the day, implicating excitatory DMH neurons in regulation 
of the above parameters.
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Chapter 1: Introduction and Background 
 
 
The Circadian timing system and its significance for human health  
The circadian timing system (CTS) is an evolutionarily ubiquitous physiological system that 
regulates daily patterns in gene expression, metabolism, and a wide array of behaviors and physiological 
functions, and synchronizes these daily rhythms to each other and to external time cues (such as daylight 
or food availability).  The CTS is among few convergent features evolved by plants, fungi, animals and 
even some prokaryotes, all of which have circadian timing systems built upon molecular feedback loops 
of approximately 24 hours duration, but based in different groups of organisms on different genes 
(Ouyang et al., 1998; Foster and Kreitzman, 2004). The ability of an organism to predict regular changes 
in its environment and time its functions and behaviors accordingly is clearly highly adaptive and selected 
for.  The circadian timing system powerfully regulates our physiology and behavior and thus influences 
our health (Moore-Ede et al., 1983). 
Chronic phase shifting (e.g. jet-lag or shift work, which forces the body to go against intrinsic 
schedules driven by the CTS), has been linked to a number of illnesses in both humans and animals.  
These include increased risk of breast cancer (Hansen, 2001), of hypertension (Kawachi et al., 1995) and 
increased mortality rate in aged animals (Davidson et al., 2006).  Prolonged lack of synchrony to external 
time cues can disrupt function of homeostatic systems in monkeys (Fuller et al., 1978) perhaps via 
gradual uncoupling of the many oscillating functions throughout the body.   
In humans there is evidence that the quality and duration of sleep depends on the circadian 
phase of its onset and its synchrony with the circadian rhythm in Tb (Czeisler et al., 1980a; Czeisler et al., 
1980b).  Sleep loss or disruption, in turn has numerous short and long-term consequences.  The 
increased blood levels of pro-inflammatory cytokines associated with sleep loss contribute to a decrease 
in neurobehavioral function and adversely affect cardiovascular function (Zheng et al., 2006).  In 
particular chronic sleep loss may contribute to the development of atherosclerosis, as indicated by sleep 
loss-dependent elevations in plasma C-reactive protein (Libby and Ridker, 2004)  
Mouse models with mutations in key genes necessary for the CTS exhibit a variety of health 
deficits including progressive arthropathy (Bunger et al., 2005), severely compromised reproductive 
health (Miller et al., 2004; Alvarez et al., 2008), increased cancer risk (Rosbash and Takahashi, 2002), 
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obesity and a metabolic syndrome related to early stage diabetes (Rudic et al., 2004; Turek et al., 2005; 
Buxton et al., 2012).  Both humans (Czeisler et al., 1999; Toh et al., 2001) and mice (Laposky et al., 
2005) with mutations in clock genes have abnormal sleep wake cycles and may suffer from secondary 
consequences of chronic sleep disturbances (see footnote1).   
  The above findings suggest that circadian organization of molecular and system-wide processes 
throughout an organism are of immense importance to overall health.  The now established connection 
between CTS disruption and cancer could be based on circadian gating of mitosis, endocrine disturbance 
or both (Okamura, 2004).  Disruption in normal levels of estrogen and its circadian and monthly rhythms 
have been linked to both cancer and reproductive compromise.  Likewise, there is evidence that temporal 
dysregulation of the hormones leptin and ghrelin may underlie the connection between chronic sleep loss 
and diabetes (Knutson et al., 2007; Van Cauter et al., 2007).  Both the CTS and sleep itself exert 
important regulatory effects on hormone secretion profiles  (Czeisler and Klerman, 1999), offering one 
possible pathway linking circadian disruption and adverse health consequences.  Another set of possible 
pathways come from potent circadian regulation of sympathetic outflow to peripheral organs (Kalsbeek et 
al., 2006b; Kalsbeek et al., 2006a).  
Whatever the pathway, loss of the adaptive temporal organization which normally exists within 
and between tissues can compromise health and fitness of the whole organism (Hastings et al., 2003).  
Understanding the neural circuitry underlying temporal synchronization of physiology and behavior may 
reveal new risk factors and mechanisms for prevention and treatment of some of the diseases and 
disorders that our society is most afflicted by in this era, including heart disease, diabetes and cancer. 
 
Circadian clocks and the suprachiasmatic nucleus 
The CTS is composed of circadian biological clocks (endogenous oscillators with a period of near  
___________________________________________________________________________________ 
1 Do genes driving the circadian timing system also affect other functions? 
It bears mention that some genes which drive the CTS are transcription factors for unrelated genes as well, 
and may have other functions in the body that contribute to or account for some of the phenotypes above.  However, 
more recent studies which disrupt expression of these genes in a tissue-specific manner (Sadacca et al., 2011) or do 
so in select brain regions of normally developed adult animals (who did not lack these genes during development) 
(Fuller et al., 2008) (Ramalingam et al., unpublished data), are beginning to tease apart this question.  The similarity 
in problems caused by external schedule disruption vs. clock gene disruption suggest that many of the health 
consequences seen as a result of knocking out circadian clock genes are in fact secondary to disruption of 24h 
oscillations in the body. 
3 
 
 
24 hours), built upon a molecular feedback loop.  In mammals, these molecular clocks are present in 
each cell of most peripheral tissues and within several structures inside the brain.  However, the site most 
important for driving systemic (behavioral and physiological) rhythms is the clock in the suprachiasmatic 
nucleus (SCN) of the hypothalamus.   
Complete bilateral ablation of the SCN has been shown to abolish circadian rhythms of locomotor 
activity, wakefulness, heart rate, feeding and drinking behavior, plasma levels of glucose, corticosteroids, 
and melatonin, and core body temperature (Tb) (however, see footnote2 concerning Tb rhythm) (Moore 
and Eichler, 1972; Raisman and Brown-Grant, 1977; Stephan and Nunez, 1977; Abe et al., 1979; 
Refinetti and Menaker, 1992; Warren et al., 1994; Moore, 1996; La Fleur et al., 1999).  The above results 
imply that the clock in the SCN is necessary for driving these rhythms.  That said, the majority of these 
lesions in the above studies likely also damaged adjacent structures or fibers of passage due to 
limitations of the techniques used (Saper, 2013), but there are numerous other lines of evidence  
____________________________________________________________________________________ 
2Are circadian rhythms in Tb generated/driven by the molecular clock in the SCN? 
 
 Various studies document that large bilateral SCN lesions eliminate circadian variation in Tb (Eastman et al., 
1984; Honma et al., 1988; Ruby et al., 1989; Scheer et al., 2005).  However several studies in which bilateral SCN 
lesions were made failed to confirm that finding.  Though SCN lesions in these studies abolished rhythms in 
locomotor activity (Fuller et al., 1981; Satinoff and Prosser, 1988) or were presumed to (Halberg et al., 1979) a 
significant rhythm in Tb remained, though perhaps with diminished amplitude.  Although technical considerations 
surrounding electrolytic SCN lesions might explain the discrepancy, for years the lesion data was interpreted as 
controversial and inconclusive. 
 Since the discovery of the molecular clock driving circadian oscillations, we have also been able to ask 
whether animals bearing mutations in various clock genes have normal Tb rhythms.  So far, this has been studied in a 
few mouse knock-outs that lack critical clock genes: the Bmal1 -/- mouse, the Clock -/- mouse and the Cryptochrome 
1 and 2 (Cry1-/- Cry2 -/-) double knock out mouse.  All of these animals show a complete loss of circadian rhythms in 
locomotor activity in constant dark (DD), but exhibit diurnal patterns of running-wheel activity in light:dark cycles 
(12:12 L:D), due to light masking.  Cry1-/- Cry2 -/- mice show no Tb rhythm in DD but rhythmic oscillations in Tb can 
be induced in LD or with a special feeding schedule (Nagashima et al., 2005).  Similarly Clock -/- and Bmal1 -/- mice 
have no Tb rhythm in DD and show very low amplitude (Clock -/-) or severely disrupted (Bmal1 -/-) Tb rhythms in LD 
(Fuller et al., 1981; Tokizawa et al., 2009).  Clearly, a functional molecular clock is critical for the generation of 
intrinsic circadian rhythms in Tb.  However, because this clock is expressed in most cells and tissues throughout the 
body, the question has been raised as to whether it is necessarily the molecular clock in the SCN that drives these 
rhythms. 
Findings from our lab show that the pacemaker in the SCN is at least sufficient (if not necessary) to drive 
rhythms in Tb, since rescue of the expression of  BMAL1  in only the SCN of total body BMAL1 knock-out mice can 
rescue the full amplitude of Tb rhythms (Fuller et al., 2008).  Recent experiments in conditional knock-out (i.e. floxed) 
BMAL1 mice  using stereotaxic injections of an adeno-associated viral vector expressing cre-recombinase, to 
selectively delete BMAL1 expression in only the SCN from our lab (Ramalingam et al., in preparation) indicate that 
deletion of BMAL1 in only the SCN severely disrupts circadian rhythms in Tb, even though the molecular clock is 
intact in every other region that would normally express it in these mice.  It appears that the molecular clock in the 
SCN is both necessary and sufficient for driving circadian rhythms in Tb. 
Moreover, lesions of the main target of SCN efferent projections, the subparaventricular zone (SPZ), 
diminish the amplitude of Tb rhythms by 80-90% (Lu et al., 2001), further supporting the idea that the clock in the 
SCN drives this rhythm, and suggesting that it does so via neural efferent outputs. 
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suggesting that the clock in the SCN drives rhythms throughout the body. 
In the case of locomotor activity, SCN transplant experiments have conclusively demonstrated 
the clock in the SCN determines the period and phase of these rhythms (Ralph et al., 1990; Sujino et al., 
2003).  More recently, selective re-expression of a critical clock gene in the SCN of otherwise arrhythmic 
knock-out animals demonstrated that the molecular clock in the SCN is sufficient for driving circadian 
rhythms of locomotor activity and Tb  (Fuller et al., 2008). 
The SCN clock is also critical for entrainment of systemic rhythms to certain external time cues, 
the 24-hour light cycle being the best studied and most effective entrainment cue.  Moreover, lesions of 
the SCN result in uncoupling of the phases of other endogenous molecular clocks (Yoo et al., 2004), and 
synchronous clock gene expression rhythms in these tissues can be restored via fetal SCN 
transplantation (Guo et al., 2006).  It is also worth noting that the loss of endocrine rhythms in SCN-
lesioned animals occurs despite the fact that local molecular clocks in all their glands and peripheral 
tissues remain fully functional (Yoo et al., 2004).  Hence, a peripheral organ’s local molecular clock 
appears insufficient to drive its secretion rhythms. 
The above evidence strongly argues that the clock in the SCN drives circadian rhythms of 
behavior and physiology, synchronizes these rhythms with each other and with other endogenous 
molecular rhythms and further, synchronizes all these rhythms with external light cycles.  While much is 
known about how the SCN receives light cycle information from specialized photoreceptors via the retino-
hypothalamic tract (Freedman et al., 1999; Gooley et al., 2001; Gooley et al., 2003), less is understood on 
how outflow from the SCN drives or synchronizes systemic and cellular rhythms, respectively. 
 
SCN outflow pathways 
Neurons of the SCN convey temporal information to other organ systems through both neural and 
humoral outputs.  The SCN has efferent neural connections to a wide array of central and peripheral 
structures and disruption of these efferents can alter or eliminate a wide array of circadian rhythms 
(Bartness et al., 2001).  However, when transplantation of fetal SCN tissue into the third ventricle of SCN-
lesioned hamsters was shown to restore rest-activity rhythms within a few days post-operatively (Ralph et 
al., 1990; Sujino et al., 2003) the question arose regarding the importance of synaptic signaling from the 
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SCN for regulation of rhythms in locomotion.  Since SCN grafts could restore some degree of rhythmicity 
in locomotor activity presumably without enough time to innervate the SCN’s normal hypothalamic 
targets, it was proposed that diffusible factors may be the means by which the SCN drives and 
synchronizes this rhythm.  Though a subsequent study found evidence of connections between graft and 
host tissue in SCN transplant recipients with restored rhythms (Aguilar-Roblero et al., 1994), polymer 
encapsulated SCN transplants that prevented neuronal communication between host and donor tissue 
were still able to restore low amplitude rhythms of locomotor activity (Silver et al., 1996; LeSauter et al., 
1997) with the amplitude increasing as the graft implant site approaches the normal location of the SCN 
near the third ventricle.  Taken together, these results suggest that rhythmic paracrine signaling from the 
SCN contributes to locomotor activity rhythms, though it alone cannot account for their full amplitude. 
To date, three SCN-secreted molecules have been proposed as candidates for the activity 
rhythm-regulating paracrine signal: prokinectin-2 (PK2) (Cheng et al., 2002), cardiotropin like cytokine 
(CLC) (Kraves and Weitz, 2006), and transforming growth factor-Į (TGF-Į) (Kramer et al., 2001), 
although it is unclear whether the latter is produced by neurons or astrocytes in the SCN.  All three show 
clock-controlled expression, peaking during subjective day in rodents, i.e. the quiescent portion of their 
activity cycle.  Infusion of TGF-Į, PK2 or CLC into the third ventricle disrupts normal rhythms of locomotor 
activity and, in the case of TGF-Į, rhythms of Tb as well.  TGF-Į and CLC produce these effects without 
affecting the underlying phase of the clock in the SCN.  All three of these molecules appear to inhibit 
locomotor activity via receptors expressed in the vicinity of the third ventricle (including the periventricular 
nucleus).  Mice with a hypomorhphic mutation of the receptor for TGF-Į have abnormal circadian activity 
profiles and fail to show the normal suppression of activity in response to light (Kramer et al., 2001). 
More recent parabiosis and SCN transplant experiments have also indicated that diffusible factors 
from may underlie the coupling of certain peripheral molecular clocks to each other and the light cycle 
(Guo et al., 2005).  However, such a signal needn’t necessarily be a secreted factor released directly by 
the SCN.  It appears more likely to be a hormone whose release is regulated by neural outputs of the 
SCN or perhaps a consequence of rhythmic food intake, since all known factors released directly by the 
SCN act in a paracrine rather than endocrine fashion. 
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One important methodological consideration regarding the studies suggesting that SCN-secreted 
factors can drive rhythms is age of the animal in which they are performed.  SCN transplants have only 
been successful in restoring activity rhythms in very young animals, and newer studies suggest that the 
influence of SCN secreted factors on sleep/wake rhythms declines during development, coincident with 
the formation of neural connections that drive these rhythms in adults (Gall et al., 2012). 
While the above summarizes the role for diffusible SCN outputs in coordination of system-wide 
rhythms, the sections that follow can only partially cover the considerably more extensive literature on 
neural efferents of the SCN and how they act to relay entrainment cues and drive rhythms throughout the 
body.  We know that neural outputs of the SCN are responsible for  entrainment of hormonal and 
physiological rhythms as SCN transplantation does nothing to restore them (Lehman et al., 1987; Meyer-
Bernstein et al., 1999) and lesions of specific synaptic targets of the SCN destroys them (Bartness et al., 
2001; Lu et al., 2001; Chou et al., 2003).  The fact that the left and right SCN can be de coupled and 
produce antiphase rhythms in their targets on each side of the brain with high temporal precision (de la 
Iglesia et al., 2003) also implicates neural as opposed to humoral outflow  (however, see footnote3).  The 
important role these efferent connections play in regulation of behavioral rhythms and arousal states is 
best illustrated by the dramatic decrease in amplitude of these rhythms following lesions of certain SCN 
projection targets and will be the subject of the passages below.  In addition, synaptic signaling is much 
faster than paracrine, and may be required to explain the high level of temporal precision with which the 
circadian system responds to environmental cues and organizes rhythms throughout the organism.  
Finally, since receptors for diffusible factors released by the SCN are expressed in hypothalamic regions 
near the third ventricle, they may well be acting on neurons which synapse onto targets of the SCN and 
thus ultimately drive outflow through some of the same circuitry. 
 
____________________________________________________________________________________ 
3 Can diffusible factor produce ipsilateral effects? 
 
Although there are rare examples where diffusible factors appear to produce effects only ipsilaterally, e.g. gonadal 
digenesis during development,  these occur over a longer time scale in a developing organism, where strong 
gradients of diffusible factors are often present to guide tissue and organ formation and developing tissues may 
exhibit differential sensitivity to signaling factors present (Houle and Taketo, 1992).  Diffusible factors are 
considerably less likely to produce ipsilateral effects on the order of minutes and in a regular, cyclic fashion in fully 
formed adult animals with symmetrical sensitivity to the factors in question. 
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Neural outputs of the SCN 
Most studies tracing neural SCN outputs have been carried out in rat (Swanson and Cowan, 
1975; Watts and Swanson, 1987; Watts et al., 1987) or golden hamster (Kalsbeek et al., 1993; Morin et 
al., 1994), although these outputs have also been mapped in mice  and in certain primates (Moore, 1993). 
Primary efferent projections from the SCN for the most part target midline structures within the 
hypothalamus although a few of them terminate in the forebrain, thalamus or midbrain.  The majority of 
these projections appear to be ipsilateral although there are exceptions.  By far the most dense projection 
is a bundle of fibers arching dorsally and caudally out of the SCN.  Most of these terminate in the  
subparaventricular zone (SPZ) though a few fibers continue dorsally to synapse on neurons in the PVH.  
Another group of fibers continues caudally to terminate in the dorsomedial nucleus of the hypothalamus 
(DMH), in the area surrounding the ventromedial nucleus of the hypothalamus (VMH), and in the posterior 
hypothalamus (PH), with a few terminals falling within the boundaries of the lateral hypothalamic area 
(LHA).  Compared to the above dorso-caudally bound collection of fibers, all other projections from the  
SCN are significantly more sparse.  Their targets include certain pre-optic hypothalamic regions including 
the median pre-optic nucleus (MNPO) and, in some tracing studies, a weak projection to the ventrolateral 
pre-optic region (VLPO).  Other targets include the lateral septum, bed nucleus of the stria terminalis 
(BSTL), retrochiasmatic area (RCA), paraventricular thalamus (PVT), paratenial thalamus, the 
intergeniculate leaflet (IGL) within the lateral geniculate thalamus (LGN), olivary pretectal nucleus (OPT), 
and part of the periacqueductal gray (PAG) area in the midbrain. 
 Given the importance of the circadian timing system in regulation of sleep-wake cycle timing and 
behavior, it is surprising how few primary SCN efferents directly target structures known to regulate sleep 
and arousal, such as the VLPO, LHA and PAG.  These areas are not even consistently identified as SCN 
output targets across tracing studies, and when reported, projections to them are characterized as 
extremely sparse.  While the tracing of primary SCN efferents revealed circuitry likely to underlie circadian 
control of endocrine rhythms (e.g. projections to the PVH which can drive pituitary secretion and 
sympathetic outflow), it generated new questions about circuitry underlying circadian regulation of 
behavior and arousal state.  As described below, it is the second and third order projections from targets 
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of the SCN’s primary efferents that have enabled us to propose a circuit diagram connecting the two 
systems. 
 
How does the circadian timing system communicate with brain regions regulating wakefulness 
and activity? 
 For the better part of the 20th century, the study of neural circuits and formal properties regulating 
sleep, arousal and related physiological parameters constituted an area separate from the study of the 
circadian timing system (or its properties and underlying anatomy).  Here, I provide a brief overview of 
some of the central pathways driving sleep and waking and then discuss several proposed regulators of 
behavioral state transition 
Arousal states can be divided into three main categories based on electroencephalogram (EEG) 
wave patterns: (1) waking; (2) rapid eye movement (REM) sleep (characterized by fast eye movements, 
atonia in muscles throughout the body except those driving eye movements and breathing, and high 
cortical activity); and (3) slow-wave or non-REM (NREM) sleep (characterized by low levels of cortical 
activity appearing as slow waves on the EEG).  A wide array of nuclei in the brainstem, midbrain and 
caudal hypothalamus, together drive or contribute to arousal via ascending projections to the cortex and 
structures in the forebrain, thalamus and hypothalamus.  This system has historically been divided into 
two groups:  
(1) the cholinergic pedunculopontine and laterodorsal tegmental nuclei which project to thalamic relay 
neurons and help activate cortical neurons in waking and REM sleep.  These cholinergic tegmental 
neurons fire most rapidly in wake and REM stages and are silent during NREM. 
(2) the monoaminergic nuclei dispersed through the brainstem, midbrain and caudal hypothalamus, 
including the serotonergic dorsal and median raphe nuclei, noradrenergic locus coeruleus, dopaminergic 
ventral periaqueductal grey matter and histaminergic tuberomammilary nucleus, which all drive activity in 
neurons of the  cerebral cortex, basal forebrain (BF) and lateral hypothalamus during waking.  Neurons in 
these monoaminergic nuclei fire at the highest rates during wakefulness, more slowly during NREM and 
are silent during REM. 
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Neurons in the LHA and BF contribute to cortical activation during wakefulness (and also REM) 
through their own projections. The aforementioned neurons from the LHA release either the peptide 
orexin or melanin concentrating hormone (MCH) while those from the BF release acetylcholine (ACh) and 
GABA.  In the LHA, separate populations drive the cortex in wake vs. REM; orexin neurons fire most 
rapidly during wakefulness and MCH neurons during REM sleep.  Many neurons on the BF fire rapidly in 
both wake and REM, so it’s not as easy to tease apart which population does what. 
 All the above structures (except MCH-ergic LHA neurons and some cells in the BF) drive arousal.  
What then, drives sleep?  Much of it seems to come from an anterior hypothalamic region called the 
ventrolateral preoptic area (VLPO).  Evidence that VLPO promotes sleep: VLPO lesions or degeneration 
with age both cause insomnia and VLPO neurons are most active during sleep and send direct inhibitory 
GABAergic and galaninergic projections to monoaminergic ARAS nuclei (Sherin et al., 1996).  The VLPO 
in turn receives direct projections from each of the monoaminergic nuclei of the ascending arousal system 
(Chou et al., 2002) and is inhibited by them (Gallopin et al., 2000).  This mutual inhibition may enable 
more rapid state transitions, minimizing the amount of time animals spend not fully awake or asleep, for 
review see (Saper et al., 2005b; Saper et al., 2005a). Orexin neurons in the LHA seem to help 
consolidate the waking state; though these neurons are not critical for arousal, loss of them leads to many 
rapid and uncontrolled state transitions throughout the day and is in fact an animal model for narcolepsy 
(Mochizuki et al., 2004).  More recent work also implicates LHA neurons expressing melanin 
concentrating hormone (MCH) in the regulation of sleep and wakefulness (Adamantidis et al., 2008; Jego 
et al., 2013), as well as neurons in the parabrachial nucleus and pre-coeruleus region (Fuller et al., 2011; 
Kaur et al., 2013), basal ganglia (Qiu et al., 2010), and parafacial zone (Anaclet et al., 2012).  
 
Connections to the circadian system 
Of the many structures important in arousal/sleep described above, the SCN only sends very 
sparse projections to the VLPO, LHA and PAG.  The SPZ, however innervates many of the same targets 
as the SCN only more densely (Watts and Swanson, 1987), which has led to the idea that it may be an 
“amplifier” of SCN signals.  One of the major targets of the SPZ, the DMH sends two very strong 
projections to arousal system structures: an inhibitory, GABA-ergic projection to the VLPO and an 
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excitatory, glutamatergic (and TRH) projection to the orexinergic cells of the LHA, having a net effect of 
driving arousal.   
Several lines of evidence support the idea that these SPZ and DMH projections are functionally 
important, and will be discussed in Chapter 2 and 3, respectively.  Among the most compelling are the 
consequences of lesions to these areas.  Cell-specific lesions of the SPZ disrupt circadian rhythms of 
activity, temperature and sleep/wake (Lu et al., 2001).  Moreover, lesioning different parts of the SPZ 
disrupted different outputs.  Ibotenic acid lesions of the dorsal region of SPZ (dSPZ) greatly reduced the 
amplitude of rhythms in body temperature (Tb) but had little effect on rhythms in activity and sleep-wake.  
Meanwhile, lesions of the ventral SPZ (vSPZ) resulted in dramatic blunting of circadian rhythms in 
locomotor activity, sleep and wakefulness with minimal effects on temperature.  Lesions of the DMH, 
which receives neural inputs mostly from the vSPZ, diminished circadian variation in locomotor activity, 
corticosteroid secretion and sleep-wake EEG patterns (Chou et al., 2003).  So in summary, the SCN 
projects to the SPZ, which amplifies its signal and targets the DMH, which stimulates arousal by exciting 
wake-promoting neurons in the LHA and silencing sleep-promoting ones in the VLPO (Figure 1.1).   
 
Homeostatic vs. circadian regulation of sleep 
Daily rhythms of behavior and arousal state are not only regulated by the circadian timing system 
but also by a separate system mediating homeostatic drive for sleep (Achermann and Borbely, 2003).  
Though the circadian and homeostatic drives for rest constitute two distinct systems, it is not easy to 
functionally separate them in experimental measurements of behavioral output, for review see (Gooley, 
2005; ).  Temporal organization of behavior is one of the most important contributions of the CTS to 
survival and evolutionary fitness.  Likewise, homeostatic systems regulating sleep duration and 
consolidations are absolutely critical for maintenance of normal performance and metabolism.  In order 
for an animal to perform at its full potential during the temporal niche which is most adaptive for them (e.g. 
when daylight helps them detect food or when their predators are asleep), the circadian and homeostatic 
control of sleep have had to evolve ways of communicating with each other so as to not send conflicting 
output signals to the rest of the body.    
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Current hypotheses about mechanism of action for the “sleep homeostat” propose that energy 
expenditure in certain brain regions during prolonged wakefulness leads to sequential de- 
phosphorylations of ATP and through them an accumulation of adenosine.  Accumulation (or 
experimental injection) of adenosine in the BF, adjacent to the VLPO, induces sleep and increased 
immediate early gene expression in the VLPO (Porkka-Heiskanen et al., 2000; Scammell et al., 2001).  
Thus, while neurons of the VLPO are inhibited by the monoaminergic arousal system and GABAergic 
DMH inputs in order to promote arousal, after many hours of wakefulness they appear to be disinhibited, 
either by adenosine itself, inputs of adenosine-sensing neurons elsewhere in the brain, or perhaps some 
combination thereof.  Our current model of homeostatic regulatory mechanisms of arousal would suggest 
that the homeostat acts on the system only by driving sleep (after a high enough sleep pressure has built 
up).  Meanwhile, it would appear that the circadian system exerts its input on sleep both by neurally 
driving arousal/activity at the appropriate times (via excitation of orexinergic LHA neurons and inhibition of 
the VLPO) and by inhibiting it during the other half of the day (via diffusible factors). 
 
 
    Figure1.1: Schematic diagram of circadian regulation of sleep and wakefulness based on previous literature.
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How does the circadian timing system communicate with brain regions regulating thermogenesis 
and heat loss mechanisms? 
 In homeotherms, body temperature is sensed by both peripheral and central neurons (Boulant, 
2006; Romanovsky, 2007; Nakamura and Morrison, 2008), integrated (compared to a “set-point”) at a 
series of hierarchically organized central regions in the hypothalamus, midbrain, brainstem and even 
spinal cord (Satinoff, 1978) and maintained within a narrow range close to 37°C via autonomic effector 
outputs triggering either heat production or loss.  Critical central structures for maintenance of core Tb 
include the pre-optic hypothalamus (median, medial and dorsolateral pre-optic areas (MnPO) and (MPA), 
the dorsal hypothalamic area adjacent to the DMH (DH), the periaqueductal gray (PAG), and raphe 
pallidus (RPa) (Yoshida et al., 2005; Benarroch, 2007; Dimicco and Zaretsky, 2007; Nakamura and 
Morrison, 2007; Yoshida et al., 2009).  Ultimate effector pathways for heat production include 
sympathetically controlled cutaneous vasoconstriction, shivering, piloerection, secretion of thyroid 
hormones and, in many mammals, activation of brown adipose tissue.  Cooling mechanisms conversely 
involve cutaneous vasodilation, evaporation of water from the respiratory tract and increased autonomic 
tone to sweat glands in furless animals like humans and salivary glands in furry animals like rats and 
dogs, which spread the fluid on their coat to promote heat loss by evaporation. 
 Although Tb in homeotherms is maintained within a rather narrow range, typically 36.5 r 1.0°C, it 
shows a very predictable circadian oscillation throughout the day peaking during the active period (night 
for rodents) and reaching its minimum near the middle of the quiescent period.  This rhythm has been 
characterized in at least 28 different animal species including avian, rodent, ovine, bovine and primate 
groups, and though there are differences in the waveform and amplitude of Tb rhythms in these groups, 
the phase angle between peak activity and temperature is relatively consistent (Refinetti and Menaker, 
1992).  Because of this correlation in the two rhythms, some have proposed that Tb rhythm is (at least in 
part) secondary to heat generated as a consequence of activity.  However, since the increase in Tb 
typically precedes the start of activity and always persists in experiments where activity levels are kept 
constant over 24 hours in humans (either via chair or bed restriction),where, its amplitude often is not 
even significantly diminished (Fuller et al., 1981; Marotte and Timbal, 1981; Czeisler et al., 1986; Gander 
et al., 1986), it is widely accepted that the Tb rhythm is generated autonomously and does not depend on 
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activity rhythms.  Because Tb is affected by many other factors including feeding, sleep, light exposure, 
hormone rhythms and acute stressors, it is important to note that experiments controlling for all of these 
have also found a persisting near-24-hour oscillation in Tb.  The primary example of such an experiment 
is Tb measurement during constant routine in humans, where sleep and feeding are controlled and evenly 
distributed into many short episodes over the circadian day, the subject remains seated or reclined for the 
duration of the experiment and all external factors (such as light level and ambient temperature) are kept 
as constant as possible (Dunlap et al., 2004)-see their chapter 9).  While this cannot be done in rodents, 
fortuitously, there are lesions that can achieve the same end.  Ablation of the dorsomedial nucleus of the 
hypothalamus (DMH) severely disrupts rhythms in locomotor activity, sleep and wakefulness, feeding and 
corticosteroid secretion, but barely reduces the amplitude of circadian rhythms in Tb in constant darkness 
(Chou et al., 2003).  Thus in both humans and rodents, we know that Tb rhythms are not dependent on 
any other physiological rhythms or external time cues, although they may be affected, enhanced or 
perturbed by these factors.   
In fact, not only is the Tb rhythm not a mere consequence of other rhythms in the body, it likely 
acts to synchronize molecular clocks throughout the body and ensure they are in phase with the SCN 
clock (see Buhr et al., 2010, Saper et al. 2013).  The clock in the SCN drives circadian rhythms in body 
temperature (Fuller et al., 2008, Ramalingam et al., unpublished data), and likely does so via efferent 
projections to the dSPZ (Lu et al., 2001), however, the downstream effectors in the neural circuit for 
rhythms in body temperature are not yet known (see footnote4). 
_____________________________________________________________________________________________ 
4The unknown pathway driving circadian oscillation in Tb: 
 
At present, there is not a good hypothesis for where the anatomical connection between the dSPZ and 
effector sites in the brain known to maintain core Tb homeostasis lies.  Large pre-optic Satinoff et al. (1982); 
(Szymusiak et al., 1985), DMH (Chou et al., 2003) and RPa (Fuller and Lu, personal communication) lesions do not 
reduce the amplitude of Tb rhythms.  In fact, MnPO and RPa lesions may even increase the amplitude of this rhythm.  
The potential role of the PAG as an integrator has not been investigated, in part because its anatomical connections 
to the CTS are relatively weak. Though its role in thermoregulation is less clear, the PVH, a major autonomic relay 
and neuroendocrine interface, receives both direct and indirect projections from the SCN.  Lesions of this region also 
do not diminish the amplitude of Tb rhythms at all (Moore and Danchenko, 2002).   
Preliminary studies from our lab show that Tb rhythms in hypophysectomized rats are completely intact and 
have, if anything, slightly higher amplitude than sham controls, likely due to lower body weight. (Vujovic, unpublished 
data).  Normal amplitude circadian oscillations in Tb also persist in rats with full chemical sympathectomy or spinal 
transections at the T2/T3 level, even during a 24 hour fast, which accounts for potential effects of rhythmic diet 
induced thermogenesis (Vujovic, unpublished data).   
It is possible that parasympathetic or non-pituitary humoral signals are the most important signals driving 
circadian oscillations in Tb, or that this rhythm is the product of several redundant outflow pathways. 
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How does the circadian timing system communicate with brain regions regulating autonomic and 
neuroendocrine functions? 
 Retrograde transneuronal tract tracing shows that the SCN is connected (presumably through 
indirect, multisynaptic pathways) to many peripheral tissues via the sympathetic and parasympathetic 
branches of the autonomic nervous system (Ueyama et al., 1999).  One important junction at which 
primary (or higher order) efferents from the SCN connect to neurons of the autonomic nervous system is 
the PVH (Teclemariam-Mesbah et al., 1997).  The PVH sends direct projections to sympathetic pre-
ganglionic neurons in the spinal cord, to pre-parasympatheitc targets in the brainstem, and drives pituitary 
hormone release via both synaptic and paracrine outputs.  Through these pathways, the PVH can 
regulate rhythms and control the phases of many endocrine outputs (Perreau-Lenz et al., 2004).   
Adrenergic signals from the sympathetic nervous system have been shown to underlie certain 
physiological responses to light, including diurnal entrainment of important rhythms.  The most thoroughly 
studied of these are rhythms of pineal melatonin synthesis (Moore, 1996; Perreau-Lenz et al., 2005) and 
adrenal corticosteroid release (Jasper and Engeland, 1994).  There are also many examples of light 
stimuli more acutely affecting sympathetically controlled or regulated functions, presumably via 
sympathetic nerve activity [e.g. ambulatory heart rate (Scheer et al., 1999; Scheer et al., 2001), adrenal 
corticosterone secretion (Buijs et al., 1999; Ishida et al., 2005; Mohawk et al., 2007), pineal melatonin  
release (Kalsbeek et al., 1996; Kalsbeek et al., 1999; Kalsbeek et al., 2000), and salivary secretion 
(Bellavia and Gallara, 2000)].  These findings suggest that both normal photic entrainment of the clock  
and intermittent light exposure (whether at appropriate or inappropriate circadian times) may affect the 
temporal organization of physiological and endocrine function through sympathetic outflow. 
Circadian rhythms in plasma glucose are thought to be dependent on GABAergic SCN 
projections to the PVH and sympathetic outflow from the PVH to preganglionic neurons that control the 
liver (Kalsbeek et al., 2004; Cailotto et al., 2005).  Rhythmic synthesis and secretion of pineal melatonin 
also depends on SCN projections to the PVH and its projections to sympathetic preganlionic neurons that 
regulate the pineal gland (Moore, 1996).   
Of most relevance for the experimental work discussed in subsequent chapters, indirect SCN 
connections to the DMH and PVH are thought to be important for driving rhythms in plasma 
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corticosteroids.  Lesions of the DMH have been shown to diminish the amplitude of corticosteroid rhythms 
(Chou et al., 2003) and the PVH (which receives input from the SCN, SPZ and DMH) regulates adrenal 
corticosteroid release both via sympathetic projections to the adrenal cortex and through the 
hypothalamo-pituitary-adrenal axis.  Both these connections from the PVH to the adrenal gland are well 
characterized.  For the latter, release of corticotrophin-releasing hormone (CRH) from parvicellular 
hypophysiotropic neurons in the PVH drives the release of adrenocorticotropic hormone (ACTH) from the 
anterior pituitary.  For the former, projections from the PVH stimulate sympathetic pre-ganglionic neurons 
in the intermediolateral column of the thoracic spinal cord which in turn drive splanchnic nerve activity, 
which can modulate adrenal function.  Further complicating matters, the molecular clock in the adrenal 
gland itself is shown to drive circadian oscillation in the expression and intracellular levels of enzymes 
responsible for corticosterone synthesis (Son et al., 2011; Ota et al., 2012).  This clock is likely sensitive 
to perturbation and, in the absence of an intact SCN is clearly not able to drive full-amplitude 
corticosterone rhythms (Moore and Eichler, 1972; Abe et al., 1979).  Furthermore, studies showing that 
CRH-knockout mice lack normal diurnal corticosteroid rhythms, and that these can be restored via 
constant infusion of exogenous CRH, suggest that a functional hypothalamo-pituitary adrenal axis is 
necessary for normal expression of these rhythms (Muglia et al., 1997).  The circadian timing system may 
regulate corticosterone rhythms via the hypothalamo-pituitary adrenal axis, by neural modulation of 
splanchnic nerve activity, via (direct or indirect) modulation humoral factors which could affect the phase 
or amplitude of local adrenal gland molecular clocks, or, most likely by some combination of the above 
factors.  It is not yet understood which neurotransmitter(s) are released by the SCN, vSPZ and DMH in 
the circuit connecting the circadian timing system to these neuroendocrine and autonomic interfaces. 
 
Neurotransmitters of the SCN, SPZ and DMH 
 Figure 1.1 (see page 11) includes some of the known neurotransmitters in the circuits underlying 
circadian influence on arousal.  However, the identity of neurotransmitter(s) used by several key neurons 
in this circuit remains to be ascertained.  With particular relevance to this proposal, it is still not known 
which transmitters are used by projections of the SCN and SPZ and certain projections from the DMH in 
the regulation of circadian rhythms of locomotor activity, sleep, corticosteroid and Tb.  Below we describe 
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some of the candidate classic transmitters and peptides acting at these sites; this is also summarized in 
Table 1.1. 
 
  
Neurons of the SCN express and synaptically release many peptides not commonly found in 
other portions of the central nervous system, but only one classic neurotransmitter, Ȗ-aminobutyric acid 
(GABA), the major inhibitory transmitter of the brain.  While GABA is expressed throughout the entire 
SCN, many peptides are expressed only in certain sub-regions of this nucleus.  The SCN is often divided 
into two main regions, the ventrolateral “core” and dorsomedial “shell” (Moore, 1983).  In the core the 
most abundantly expressed peptide transmitter is vasoactive intestinal polypeptide (VIP) but many core 
neurons also contain gastrin releasing peptide, neurotensin or peptide histidine isoleucine (PHI), a 
peptide made from same precursor as VIP and thus often co-expressed with VIP within individual 
neurons.  By contrast, the shell of the SCN can be anatomically defined by immunostaining for arginine 
vasopressin (AVP) but also stains with antisera for the hormones angiotensin II and enkephalin.  Two 
other peptides, somatostatin and substance P are expressed by SCN neurons along the core-shell 
border. 
 Of the above transmitters AVP, VIP and GABA are considered to be three of the most important.  
Expression of each of these transmitters in the SCN has been experimentally disrupted, with varying 
SCN SPZ 
 
DMH 
GABA 
 
core/ventrolateral: 
vasoactive intestinal polypeptide(VIP) 
gastrin releasing peptide (GRP) 
neurotensin (NT) 
peptide histidine isoleucine (PHI) 
 
shell/dorsomedial: 
arginine vasopressin (AVP) 
angiotensin II 
enkephalin 
 
boundary: 
somatostatin (SOM) 
substance P (SP) 
 
GABA 
dopamine  
 
GABA 
glutamate (VGlut2 only)  
thyrotropin releasing hormone (TRH) 
orexin (ORX) 
alpha atrial natriuretic peptide (Į-ANP) 
alpha cholecystokinin Į-CCK 
Į-MSH (sparse & in caudal region) 
 
Table 1.1: Neurotransmitters expressed in the SCN, SPZ and DMH.  
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results.  AVP-deficient Brattleboro rats appear to have normal behavioral rhythms, (Peterson et al., 1980; 
Groblewski et al., 1981), however AVP receptor V1a knockout mice show a lowered amplitude circadian 
rhythm in locomotor activity  and eventually become arrhythmic after a few weeks in constant darkness, 
(Li et al., 2009).  VIP and PHI knock-out mice exhibit a reduction in the amplitude in circadian wheel-
running rhythm (Colwell et al., 2003) as do knockouts for the VIP receptor VPAC2 (Kallo et al., 2004).  All 
of these mice still show normal light entrainment and diurnal activity rhythms in a light-dark cycle, 
however this may be a consequence of light masking (i.e. behavior driven directly by light and instead of 
a light-entrained endogenous clock).  Importantly, several targets of VIP-containing SCN projections 
express VPAC2, including the SPZ, PVH and lateral septum (Kallo et al., 2004).  GABAergic outputs of the 
SCN appear to drive circadian rhythms of plasma glucose (Kalsbeek et al., 2004) and may be important 
for entrainment of melatonin (Kalsbeek et al., 1999), locomotor activity and temperature rhythms (Fuller, 
personal communication). 
Not surprisingly, the SPZ, the main target of SCN output fibers, receives input from both the shell 
and core of the SCN.  VIP-ergic fibers from the SCN core tend to project to more lateral portions of the 
SPZ, while AVP-immunoreactive fibers from the SCN shell target the medial SPZ (Leak and Moore, 
2001).  It is not clear whether there is any difference in SCN inputs to the functionally distinct dorsal and 
ventral subdivisions of the SPZ. 
Unlike the SCN, the SPZ does not appear to express any known peptide transmitters.  Instead, 
neurons throughout this nucleus express primarily GABA, the major inhibitory neurotransmitter.  A few 
dopaminergic somata may also be seen in medial parts of the SPZ, overlapping with A14, a well-
characterized dopaminergic zone in the periventricular nucleus of the hypothalamus. 
About equal numbers of neurons in the DMH express markers for GABA or glutamate, and in 
addition many neurons of the DMH express various peptides (Chou et al., 2003).  These include 
thyrotropin releasing hormone (TRH), orexin (ORX), alpha atrial natriuretic peptide (Į-ANP), alpha 
cholecystokinin Į-CCK, and to a lesser extent, melanin concentrating hormone (MCH) in the caudal DMH. 
 It should be noted that unlike peptidergic neurons, GABAergic and glutamatergic neurons cannot 
be identified simply by the presence of GABA or glutamate in terminals.  Since it is one of the 20 essential 
amino acids, glutamate is present in all cells and is very difficult to label with a good signal-to-noise ratio 
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using an antibody.  Glutamate is the precursor for GABA, which itself is also not a good target for 
immunohistochemistry.  The enzyme which converts glutamate to GABA, glutamic acid decarboxylase 
(GAD) is a good marker for neurons which produce GABA.  In mammals, it is present in two isoforms, 
GAD-65 and GAD-67, both detectable through immunohistochemistry and in situ hybridization.  However, 
the clearest indicator that a neuron releases a given transmitter is the presence of its vesicular transporter 
(i.e. the protein pump which packages the transmitter into synaptic vesicles).  All the GABA-ergic 
neuronal populations discussed above were confirmed as such through their expression of vesicular 
GABA transporter (VGAT).  Three separate isoforms of vesicular glutamate transporter (VGlut1, VGlut2 
and VGlut3) are present in the mammalian nervous system, each expressed in distinct regions.  The 
glutamatergic neurons of the SPZ and DMH all express VGlut2. 
 
Rationale for experimental work presented in Chapter 2 and 3 
Tracing efferent projections from the SPZ 
As described above, the SPZ is the main recipient of SCN efferents and has been shown to play 
an important role in relaying information from the SCN clock to other brain regions.  Cell-specific lesions 
of the ventral subdivision of the SPZ cause a profound reduction in the amplitude of locomotor activity 
and sleep-wake rhythms, while having only modest effects on the amplitude of the circadian rhythm in 
body temperature.  Cell-specific lesions of the dorsal SPZ produce the opposite effect, severely reducing 
the amplitude of body temperature (but not activity and sleep-wake) rhythms.  It would seem that the 
dorsal and ventral SPZ may have differences in terms of their neural inputs and outputs that underlie this 
difference in physiological function.  However, when inputs to the SPZ are examined, the most striking 
differences are seen between innervation of the medial vs. lateral SPZ, with the former receiving much 
more robust input from the SCN shell and the latter from the SCN core and from the retina.  This suggests 
that the medial vs. lateral SPZ may also have differences in function that are not yet understood.  To gain 
a better idea of what roles each subdivision of the SPZ may play, and to test hypotheses about which 
SPZ efferents could be driving normal rhythms in activity and sleep vs. body temperature, we divided this 
region into four quadrants (the ventromedial, ventrolateral, dorsomedial, and dorsolateral SPZ) and 
placed injections of anterograde tracer into each.    
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Selective disruption of glutamatergic neurotransmission from DMH neurons 
The DMH is a major relay and integrator in the circuitry through which circadian patterns in 
arousal state, behavior and endocrine rhythms are temporally organized, and various homeostatic 
parameters are regulated.  As mentioned, cell-specific lesions of the DMH produce a significant reduction 
in the amplitude of circadian rhythms of locomotor activity, sleep-wake, corticosteroid secretion and 
feeding.  They also result in lowered overall wakefulness, activity, plasma cortisol and body temperature.  
Although it is clear that the DMH occupies a prominent role in the neural pathway connecting the 
circadian timing system to effector circuits driving changes in behavioral state, temperature and endocrine 
output, it is not known which neurotransmitter(s) it releases to drive downstream targets.  It has been 
proposed that excitatory glutamatergic projections from the DMH to wake-promoting neurons of the LHA 
and inhibitory GABAergic inputs from the DMH to sleep-promoting neurons in the VLPO may be critical 
for circadian modulation of activity and feeding rhythms.  Circadian regulation of corticosteroid release 
may depend on an excitatory projection from the DMH to cortictropin releasing hormone-expressing 
neurons in the paraventricular hypothalamus (PVH).  Evidence the above hypothesis comes from 
neuroanatomical and physiological studies in the rat.  We aim to test the extent to which glutamatergic 
outputs of the DMH drive circadian oscillation in locomotor activity, feeding and corticosteroid release, 
and absolute levels of body temperature, locomotor activity and corticosterone production. 
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Chapter 2: Efferent projections of the subparaventricular zone: does the circadian timing system 
have a four-channel output? 
 
Abstract 
The subparaventricular zone of the hypothalamus (SPZ) is the main efferent target of neural 
projections from the suprachiasmatic nucleus (SCN) and an important relay for the circadian timing 
system.   Although the SPZ is fairly homogeneous cytoarchitecturally and neurochemically, it has been 
divided into distinct functional and connectional subdivisions.  The dorsal subdivision of the SPZ (dSPZ) 
plays an important role in relaying signals from the SCN controlling body temperature rhythms while the 
ventral subdivision (vSPZ) is critical for rhythms of sleep and locomotor activity (Lu et al., 2001).  On the 
other hand, the medial part of the SPZ receives input mainly from the SCN shell, whereas the lateral SPZ 
receives input from the SCN core and the retinohypothalamic tract (Leak and Moore, 2001).  We have 
therefore investigated whether there are corresponding differences in efferent outputs from these four 
quadrants of the SPZ (dorsolateral, ventrolateral, dorsomedial and ventromedial) by a combination of 
anterograde and retrograde tracing.  We found that while all four subdivisions of the SPZ share a similar 
backbone of projections to the septal region, thalamus, hypothalamus, and brainstem, each segment of 
the SPZ has a specific set of targets where its projections dominate.  Furthermore, we observe intra-SPZ 
projections of varying densities between the four subdivisions.  Taken together, this pattern of 
organization suggests that the circadian timing system may have several parallel neural outflow pathways 
that provide a road map for understanding how they subserve different functions. 
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Introduction 
In mammals, daily rhythms in physiology and behavior are driven by rhythmic outputs from the 
pacemaker in the suprachiasmatic nucleus (SCN).  The adjacent subparaventricular zone (SPZ), which 
receives the majority of neural efferent fibers from the SCN (Watts et al., 1987; Leak and Moore, 2001), is 
thought to be a critical relay for driving rhythms.  Lesions of the SPZ (Lu et al., 2001; Schwartz et al., 
2009) or knife cuts through it (Inouye and Kawamura, 1979) can dramatically attenuate circadian rhythms 
of sleep, locomotor activity, body temperature, and multiunit activity of neurons in several other brain 
regions.  Studies showing that multiunit activity in the SPZ has a consistent phase relationship to that in 
the SCN and to locomotor activity rhythms (Inouye and Kawamura, 1979; Kubota et al., 1981; Sato and 
Kawamura, 1984; Nakamura et al., 2008) further support the notion that it is involved in SCN outflow 
circuitry.  Differences in the timing of rhythms of immediate early gene expression in the SPZ of rodents 
active at different times of day suggest that the SPZ may also modify the SCN signal, and perhaps play a 
role in establishing the diurnality or nocturnality of an animal (Smale et al., 2001; Schwartz et al., 2004; 
Todd et al., 2012). 
 Though the SPZ is fairly homogeneous morphologically, it may have different functional 
subdivisions.  Cell-specific lesions in the more dorsal and caudal half of the SPZ (dSPZ) dramatically 
reduce the amplitude of body temperature rhythms, but not locomotor activity and sleep rhythms, while 
lesions in the more ventral and rostral portion (vSPZ)  significantly blunt rhythms in activity and 
sleep/wakefulness, largely sparing temperature rhythms (Lu et al., 2001).  On the other hand, anatomical 
data suggests that the SPZ may be organized into medial vs. lateral subdivisions.  Outputs of the SCN 
core (also called the ventrolateral or retinorecipient region of the SCN), which is chiefly responsible for 
circadian entrainment to light, preferentially innervate the lateral portion of the SPZ, while the SCN shell 
(or dorsomedial SCN), thought to be more involved in pacemaking and output, projects more to the 
medial portion of the SPZ (Leak et al., 1999; Leak and Moore, 2001; Moore et al., 2002; Aton and 
Herzog, 2005).  The lateral SPZ also receives far more robust direct retinal input, (Johnson et al., 1988; 
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Levine et al., 1991; Costa et al., 1999; Gooley et al., 2003; Canteras et al., 2011), suggesting it may be 
more closely tied to functions that are sensitive to light levels. 
 The above observations suggest that the SPZ may have four distinct subregions (dorsal vs. 
ventral, medial vs. lateral), which we hypothesize should underlie regional differences in function.    
Although previous studies have examined SPZ efferents using anterograde tracing in rats (Watts et al., 
1987; Deurveilher et al., 2002; Chou et al., 2003; Deurveilher and Semba, 2003, 2005; Canteras et al., 
2011) and other rodents (Morin et al., 1994; Kriegsfeld et al., 2004; Schwartz et al., 2011), none of these 
have explored differences in projections from these different SPZ subdivisions.  We have used a 
combination of anterograde and retrograde tracing to identify distinct projections from each of the SPZ 
subregions that provide a map for exploring their functional specificity.  
 
Materials and Methods 
Animals and surgery 
All protocols used in this study were approved by the Harvard University and Beth Israel 
Deaconess Medical Center Animal Care and Use Committees and conform to the regulations detailed in 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals.  Adult male Sprague-
Dawley rats weighing 350-400g were obtained from Harlan, and housed individually in a 12:12hour light 
dark cycle with ad libitum access to water and food (Purina rodent chow). Surgeries to inject tracer were 
performed as described previously (Chamberlin et al., 1998).  Briefly, rats were anesthetized with an 
intraperitoneal injection of either chloral hydrate (350 mg/kg)  or ketamine-xylazine (80mg/kg ketamine, 
8mg/kg xylazine) and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA).  Under 
aseptic conditions the brain was exposed and an injection of tracer delivered through a fine (20 ȝm tip 
diameter) glass micropipette by using a compressed air puff system.  The skin was then closed with 
wound clips and the animals given subcutaneous injections of the analgesic meloxicam (1 mg, daily for 
two days) or flunixin (1 mg/kg, every 12 hours for two days). 
 
 
 
32 

Tracers and coordinates 
Retrograde tracing was accomplished using 3-10nl injections of Cholera toxin subunit B (CTb) (10 
µg/µl saline, List Biological, Campbell, CA), whereas anterograde tracing was done using either 3-15 nl 
injections of biotinylated dextran amine (BDA) (125 µg/µl saline, Molecular Probes, Eugene, OR) or 7-
20nl of a solution containing adeno-associated viral vectors (either serotype 2 or 8) bearing a gene for 
green fluorescent protein (AAV-GFP), prepared by the Harvard Gene Therapy Initiative Virus Production 
Core as described previously (Chamberlin et al., 1998).  This vector selectively transduces neurons near 
the injection site, which then produce GFP that fills the entire cytoplasmic compartment (including fibers 
and terminals), without causing inflammatory astrocytic or microglial responses in the surrounding tissue, 
and with minimal retrograde transport.  Animals injected with CTb or BDA were perfused one to two 
weeks following surgery, but we allowed five to nine weeks between injection of AAV-GFP and perfusion, 
to ensure adequate filling of the terminals of transduced neurons.  All injection coordinates were based on 
the atlas of Paxinos and Watson (Paxinos and Watson, 2005) (1986) and were as follows: VMH (AP -2.2; 
DV -8.8; RL +0.3), DMH (AP -3.5;  DV -8.5; RL +0.5), VLPO (AP +0.4;  DV -8.4; RL +0.9), SPZ/SCN 
(injections placed at 16q angle AP -1.75; DV -8.6; RL +2.6).  We also examined brain tissue from rats 
which received intraocular injections of 4µl AAV-GFP in a previous study (Gooley et al., 2003). 
 
Tissue Preparation 
One to nine weeks following the injection, rats were deeply anesthetized with chloral hydrate (500 
mg/kg) and transcardially perfused with 0.9% saline followed by 10% neutral buffered formalin (Sigma).  
Brains were removed and postfixed for approximately 3 hours in formalin then allowed to equilibrate for at 
least 12 hours in a 20% sucrose solution in phosphate buffered saline with 0.01% sodium azide.  Brains 
were subsequently sectioned at 40 ȝm on a freezing microtome into five series. 
 
Immunohistochemistry 
Immunohistochemistry was performed on floating sections following a protocol described in 
previous publications (Bruinstroop et al., 2011).  Sections were rinsed at least three times for 5-10 
minutes in 0.1M phosphate buffered saline (PBS), pH 7.4, for 1 hour, then were incubated in 0.3% 
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hydrogen peroxide to block endogenous peroxidase activity.  Following at least three more rinses in PBS, 
sections were incubated for at least 10 hours in a solution containing the appropriate primary antibody 
(see below) in PBS containing 0.3% Triton X-100 and 0.01% sodium azide.  Sections were then rinsed at 
least three more times in PBS before a one-hour incubation in a corresponding secondary antibody (see 
below for specific information), rinsed three more times in PBS, and then incubated for 60-90 minutes in 
an avidin-biotin complex solution (Elite ABC, Vector Laboratories).  After three more PBS rinses, the 
tissue was moved to a solution containing 1% 3,3’-diaminobenzidine (DAB) and reacted with 0.01% 
hydrogen peroxide to visualize the sites containing antigen in the tissue.  Once the desired staining 
intensity was reached, this reaction was quenched with several rinses of the tissue in a PBS solution 
containing 0.01% sodium azide.  Sections were then mounted onto gelatin coated glass slides and 
allowed to dry overnight at room temperature.  This was followed in some cases by silver-gold 
enhancement and/or counterstaining with thionin.  Silver-gold enhancement consisted of a 30 - 45 minute 
incubation of desalinated slides in 1% silver nitrate solution at 56 qC, followed by three rinses with water, 
a 10-20 minute incubation in 0.1% gold chloride, three more rinses and a brief treatment with 5% sodium 
thiosulfate solution until the tissue reaches the desired background level.  All slides were rinsed in distilled 
water before they were dehydrated in graded alcohols then cleared in xylene for at least 2 hours and 
cover-slipped with Permaslip medium (Alban Scientific, St. Louis, MO).  Counterstained sections were 
incubated briefly in thionin solution and differentiated in acid alcohol prior to dehydration. 
 Neurons labeled with the AAV-GFP vector were visualized with a primary antibody against GFP 
raised in rabbit raised against Aquaphora GFP protein (Molecular probes/Invitrogen ca# A6455 Lot# 
771568), used at a concentration of 1:20,000 followed by biotinylated donkey anti-rabbit secondary 
(Jackson Immunoresearch Laboratories) used at a 1:1,000 dilution.  This GFP antibody does not stain 
anything in tissue from uninjected animals. Tissue from cases injected with BDA underwent the same 
steps in the avidin-biotin staining protocol, except did not require primary or secondary antibodies.  For 
retrograde tracing cases, immunohistochemistry was done with a primary antibody against CTb raised in 
goat against CTb protein, used at a 1:25,000 dilution, followed by a biotinylated donkey anti-goat 
secondary (Jackson Immunoresearch Laboratories) used at a 1:1,000 dilution.  This antibody does not 
stain anything above background level in tissue from uninjected animals. 
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 For AVP/VIP double fluorescent immunolabeling, brains from a transgenic line of AVP-GFP 
reporter rats (Ueta et al., 2008), a generous gift from the laboratory of Dr. Charles Allen, were stained for 
VIP, and GFP signal in AVPergic cells was amplified immunohistochemically.  Tissue was incubated for 
two nights with a polyclonal primary antibody raised in rabbit against synthetic VIP coupled to bovine 
thyroglobulin with a carbodiimide linker (ImmunoStar, cat# 20077, lot: 722001) at a concentration of 
1:1,000 and a monoclonal primary antibody raised in mouse against Aquaphora GFP protein (Molecular 
probes/Invitrogen ca# A11120 Lot# 71C1-1), used at a concentration of 1:500.  VIP antibody specificity 
was validated by preadsorption with VIP (which abolished staining) vs. related peptides (which did not), 
as described in the manufacturer’s technical information.  Patterns of VIP labeling in the SCN and 
proximal areas also matched that reported in previous publications (Hattar et al., 2006; Belenky et al., 
2008).  The GFP antibody did not stain anything in wildtype rat brains.  After incubation with primary 
antibodies, tissue was taken through six 3-minute long PBS rinses, prior to incubation with a pre-
adsorbed biotinylated donkey anti-rabbit secondary (Jackson Immunoresearch Laboratories).  This 
secondary antibody, at a 1:100 concentration, was pre-adsorbed for 1 hour with a solution of rat brain 
powder to decrease non-specific background labeling.  The solution was then centrifuged, and only the 
supernatant was incubated with tissue for immunolabeling.   Following this 1-hour incubation, tissue was 
rinsed five times for three minutes, then incubated for 30 minutes in a solution containing an Alexa 488-
tagged donkey anti-mouse secondary antibody (Invitrogen), used at 1:500, and biotinylated Cy-3 used at 
1:500. Rinsed tissue was mounted onto slides and allowed to dry in a darkened chamber before it was 
cover-slipped with Dako fluorescent mounting medium (Dako, Carpinteria, CA). 
 
Illustration and photography 
Slides were examined and brightfield/darkfield photomicrographs were acquired with a Zeiss 
Axioplan 2 microscope with a 1.5 megapixel color Evolution MP camera (MediaCybernetics, Bethesda, 
MD) using Axiovision software.  Dual labeling immunofluorescence images were acquired using a Zeiss 
LSM 510 confocal microscope and processed using ImageJ software. All images were then processed 
with Adobe Photoshop software to optimize the brightness/contrast.  Red fluorescence was shifted to 
magenta in some images to make the difference from green visible to viewers with red-green color-
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blindness (Fig. 2.1A-C) and in images of DAB-stained injection sites, red, orange, and yellow hues were 
partially desaturated to distinguish between the injection site and fibers radiating at high density from it 
(Fig. 2.1D-I, 2.4).  Illustrations of injection sites and anterogradely labeled fibers were made using a Leitz 
Wetzlar camera lucida attachment on a Letiz LaborluxS microscope (Germany).  These drawings were 
digitized using a Wacom Intuos PTK-1240 tablet and Adobe Illustrator Software. 
 
Results 
SCN and retinal afferents to the SPZ define its medial and lateral subdivisions 
The SPZ is defined by the dense terminal area occupied by axons from the SCN rather than by 
any characteristic cytological pattern.  In Nissl sections it is not possible to divide the SPZ into regions, or 
even to differentiate it from the rest of the periventricular nucleus or anterior hypothalamic area.  For 
these reasons we have used the inputs to the SPZ from the retina and the SCN to clarify its medial vs. 
lateral organization and to designate the regions we will refer to as the dmSPZ, dlSPZ, vmSPZ and vlSPZ 
throughout subsequent analysis. 
To visualize SPZ inputs from both major SCN subregions, we took tissue from rats in which cells 
containing arginine vasopressin (AVP), a marker for many neurons in the SCN shell, natively express 
green fluorescent protein and labeled it with an antiserum against vasoactive intestinal polypeptide (VIP) 
a marker for many neurons in the SCN core (Leak and Moore, 2001, Moore et al. 2002) (see Fig. 2.1A-C).  
AVP and VIP positive fibers course dorsally and caudally from the SCN, with the densest region of 
immunoreactive fibers and terminals defining the SPZ.  VIP-immunoreactive fibers and terminals in the 
SPZ are densest in the more lateral aspects of the SPZ, and rarely are found in the 100 µm or so along 
the edge of the third ventricle.  AVP-immunoreactive fibers, on the other hand, course through the more 
medial aspect of the SPZ, closer to the wall of the third ventricle, but are rarely found in the most lateral  
150 µm or so of the territory marked by the VIP axons.  The two fiber groups overlap in the middle 150 
µm or so of the SPZ.  The source of these VIP fibers is unambiguous, as there are no other major VIP-
expressing cell groups or fiber pathways in the hypothalamus.  However, AVP-immunoreactive cell 
bodies in the paraventricular and periventricular hypothalamic nuclei make the origin of the AVP- 
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Figure 2.1 A series of photomicrographs to illustrate topographic specificity of afferent inputs to 
the subparaventricular zone from (A, B, C) neurons (in the SCN) expressing arginine 
vasopressin (green) vs. neurons labeled for vasoactive intestinal polypeptide (magenta), (D, E, 
F) retinal ganglion cells transduced with AAV-GFP (with immunohistochemical enhancement of 
GFP signal), and (G, H, I) SCN shell neurons transduced with AAV-GFP (with 
immunohistochemical enhancement of GFP signal), photographed at (A, D, G) the level of the 
SCN, (B, E, H) the level of the rostral/ventral SPZ, and (C, F, I) the level of the caudal/dorsal 
SPZ.
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Figure 2.1 (continued) 
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immunoreactive fibers in the SPZ less clear.  To address this, we also placed an injection of AAV-GFP 
selectively into the SCN shell (Fig. 2.1G-I).  Fibers and terminals originating in the SCN shell were 
present medially along the third ventricle extending out laterally to cover all of the medial SPZ and a 
fraction of the lateral, avoiding approximately the most lateral one-fourth of the SPZ.  More axonal 
ramification was seen laterally at intermediate levels of the SPZ (Fig. 2.1H) than at the most 
rostral/ventral or caudal/dorsal.  In a case in which AAV-GFP had been injected into the eye (as 
described in (Gooley et al., 2003)), the labeled retinal axons mainly occupied the lateral part of the ventral 
SPZ (see Fig. 2.1 D-F).  Based on the above findings, we therefore identify the SPZ in rats as a zone 
about 400µm wide extending dorsally and caudally from the SCN along the third ventricle, in which the 
medial half is dominated by SCN shell input and the lateral half by SCN core and retinal input. 
Furthermore, there is an exclusive area, about 100 µm wide on the medial, and 150 µm wide on the 
lateral side of the SPZ that receives input from only the medial or lateral pathway, respectively, with a 
zone of overlap of about 150 µm in the center of the SPZ.  We further divided the SPZ, based upon 
earlier physiological findings and the extent of retinal input, into a ventral zone extending about 600µm 
dorsally and caudally from the border of the SCN and a dorsal zone, extending about 600µm ventrally 
and rostrally from the border of the paraventricular nucleus.    
 
Injections of anterograde tracer into the subparaventricular zone   
Twenty-four cases had injections that included at least some part of the SPZ. We selected ten 
AAV-GFP injections and two BDA injections placed most focally within the SPZ for analysis of SPZ 
subregion targets (Fig. 2.2). 
In case 2569 (Fig. 2.2A), the injection was placed in the vlSPZ. This injection filled most of the 
vlSPZ and involved little else, although a few neurons along the dorsal margin of the SCN were included.  
In case NVA84 (Fig. 2.2A), the injection was placed into the vmSPZ, extending to laterally to include a 
part of the vlSPZ and just a few cells along the dorsal surface of the SCN shell, but not the most dorsal 
aspect of the vmSPZ.  In cases NVA36 and NVA37 (Fig. 2.2A), the injections predominantly involved 
vmSPZ neurons, but extended considerably further into adjacent areas than NVA84.  However, they did 
confirm the projection pattern from the vmSPZ as identified in NVA84.   
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Figure 2.2 Camera lucida plots illustrating placement of SPZ injection sites in cases used for 
comparative analysis across the four SPZ subdivisions at (A) the level of the rostral/ventral SPZ 
and (B, C) the level of the caudal/dorsal SPZ 
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In cases 2567 (Fig.2.2B) and NVA140 (Fig. 2.2C), the injections were confined to the dlSPZ, 
while the injection sites in cases NVA44 (Fig. 2.2C) and NVA144 (Fig. 2.2B) include both dlSPZ as well 
as some adjacent cells in parts of the anterior hypothalamic area that receive few  direct SCN efferents.  
In case NVA64 (Fig. 2.2B), the injection was placed selectively in the dmSPZ, whereas in cases NVA22, 
NVA21 (Fig. 2.2C) and NVA142 (Fig. 2.2C) the injections included dmSPZ neurons as well as a few 
neurons in the PVH.  We found no major differences in projections labeled by comparable injections using 
AAV-GFP (e.g., NVA140) vs. BDA (Case 2567) except that AAV-GFP often provided better filling of 
axons innervating the most distal targets. 
 
Efferent projections from the subparaventricular zone 
We found that although the backbone of major output pathways was similar after injections in 
each quadrant of the SPZ, there were substantial differences in the patterns of terminal areas that were 
innervated.  Most of these projections were similar to earlier descriptions (Watts and Swanson, 1987; 
Morin et al., 1994; Kriegsfeld et al., 2004; Deurveilher and Semba, 2005), but a few of the longer 
projections (e.g., to the amygdala and brainstem) had not been previously reported.  To put these into 
perspective and to provide a background for considering the specific origins of particular projections, we 
first provide an overall description of the backbone pathways from which the terminal fields emerge 
 with the aid of case NVA36.  Although the injection in this case was centered in the vmSPZ, it also 
included parts of the adjacent vlSPZ and dmSPZ.  More importantly, all of the common major pathways 
that were labeled in the other experiments were seen in this example (Fig. 2.3).  We will then focus on the 
differences between the most densely labeled terminal areas after injections in specific quadrants of the 
SPZ.    
 It is convenient to describe the projections labeled in case NVA36 based on the four major 
directions of outflow, rostral, dorsal, caudal and lateral.  Most projections were predominantly on the 
ipsilateral side of the brain, with a much smaller number of axons forming a similar pattern on the other 
side of the brain, although a few sites identified below had more extensive contralateral projections.  
These appeared to cross the midline mainly as part of the ventral supraoptic commissure.  
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Figure 2.3 A series of camera lucida drawings illustrating the pattern of axonal labeling in case 
NV36.  Note presence of fibers in the dorsal raphe, lateral parabrachial nucleus, pre-coeruleus 
region, locus coeruleus and Barrington’s nucleus 
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Figure 2.3 (continued) 
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Figure 2.3 (continued) 
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Rostral projections 
This group of axons richly innervated the rostral periventricular nucleus, medial and median pre-
optic nuclei and to a lesser extent, the anterior hypothalamic area.  Fibers continued rostrally to provide a 
dense terminal field in the anteroventral periventricular nucleus and the ventromedial preoptic nucleus.  
Slightly less dense innervation was present in the adjacent ventrolateral preoptic nucleus and relatively 
few fibers are seen further laterally in the nucleus of the horizontal limb of the diagonal band, the ventral 
pallidum, and the substantia innominata.  A considerably heavier group of fibers coursed anterodorsally, 
many of them hugging the ventral boundary of the anterior commissure, with some terminating in the 
parastrial nucleus.  Many fibers from this trajectory continued anterodorsally to terminate in the bed 
nucleus of the stria terminalis, the lateral septal nucleus (chiefly in the ventral subdivision of this nucleus), 
and a few in the medial septal nucleus.  
 A clearly distinct subpopulation of fibers in the rostral pathway diverged from the rest at 
approximately the level of the optic chiasm and coursed dorsolaterally in a diagonal path to merge with 
the stria terminalis.  These fibers terminated in the medial nucleus, and to a lesser extent the central 
nucleus of the amygdala. 
 
Dorsal projections 
This outflow pathway from the SPZ was perhaps the most robust.  Fibers coursed from the 
injection site dorsally along the third ventricle to the foramen of Monro, where they turned caudally to 
innervate the paraventricular nucleus of the thalamus (PVT).  At more caudal SPZ levels, smaller 
numbers of axons penetrated the paraventricular nucleus of the hypothalamus and thalamic reuniens 
nucleus (which they sparsely innervated), to reach the PVT.  Some axons left the PVT laterally to form 
boutons in the paratenial nucleus of the thalamus or in the lateral habenular nucleus.  The PVT was one 
of the SPZ’s most densely innervated targets, receiving SPZ projections along its full rostrocaudal extent, 
with the densest projection targeting the rostral aspect of this nucleus on the side ipsilateral to the 
injection site. 
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Caudal projections 
The pathway from the SPZ to more posterior hypothalamic structures and ventromedial midbrain 
targets was also one of its most robust outputs, and as will be discussed later, axons from different SPZ 
subregions innervated specific targets.  The axons in this pathway coursed caudally along the wall of the 
third ventricle, providing variable amounts of innervation to the ventromedial (VMH) and dorsomedial 
(DMH) hypothalamic nuclei.  In case NVA36, there was an exceptionally dense cluster of fibers and 
boutons around the capsule and perimeter of the VMH, and moderate innervation of the central division of 
the VMH, but comparatively sparser innervation to the dorsomedial or ventrolateral divisions of the VMH.  
Many fibers coursed along the medial and ventromedial edge of the VMH, filling the internuclear space 
between it and the DMH, periventricular nucleus, and arcuate nucleus, and innervating these adjacent 
structures as well.  In case NVA36 the DMH received moderate innervation throughout its rostrocaudal 
extent, which was most dense in the medial portion of this nucleus and tapered toward its lateral edge.  
Input to the arcuate nucleus was largely confined to its lateral division and was denser at caudal levels of 
the nucleus.  Case NVA36 showed a very rich input to the median eminence, with a dense terminal field 
in both the internal and external laminae ipsilaterally and a fairly dense plexus of boutons and fibers in 
only the external lamina contralaterally.  Fibers continued caudally to the premamillary, supramammilary, 
and medial mamillary nuclei with the latter two showing greater bilateral symmetry than other targets.  
Fibers also extended ventrally to line the ventral edge of the mamillary body itself.  At the premammillarly 
level, a subset of caudal pathway axons projected posterolaterally with a few fibers curving ventrally to 
terminate in the ventral tuberomamillary nucleus and others coursing laterally through (or just dorsal to) 
the substantia nigra pars compacta, likely giving rise to the terminal field seen in the thalamic 
intergeniculate leaflet. 
 The remainder of the fibers in the caudal pathway flowed dorsomedially through the posterior 
hypothalamic area into the central gray matter and Edinger-Westphal nucleus.  Occasional fibers 
branched outward from the periaqueductal gray matter to end on nearby caudal targets, such as the 
dorsal and caudal linear raphe nuclei, and the pretectal area.  A small number of fibers traversed the 
tectum, often passing along the midline between the superior and inferior colliculi.  As the cerebral 
aqueduct opened into the fourth ventricle, the fibers in the periaqueductal gray matter provided modest 
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innervation of the lateral parabrachial nucleus (bilaterally), the pre-coeruleus area (ipsilaterally) and a few 
fibers reached the ipsilateral locus coeruleus and Barrington’s nucleus as well.  
 
Lateral projections  
This outflow from the SPZ was more sparse than the rostral, caudal, or dorsal outflow.  Axons 
exiting the SPZ laterally innervated neurons in the anterior hypothalamic area and lateral hypothalamic 
area.  This projection was bilateral although much more dense ipsilaterally.  While innervation patterns in 
the lateral hypothalamus were fairly similar across injection cases, there was considerably more variability 
in the anterior hypothalamic area, particularly the subregion flanking the SPZ, which varied depending 
upon placement of the injection in the SPZ.  Other laterally-bound fibers first descended ventrally and 
then coursed laterally along the optic tract in the supraoptic decussation, forming terminals along the way 
in the retrochiasmatic area and the supraoptic nucleus.  Fibers were present along the optic tract at all 
levels bilaterally, and a subset of these may give rise to the small terminal field seen in the intergeniculate 
leaflet. 
 
Subparaventricular zone subregions differ most in their intrahypothalamic efferent projections  
Whereas the four SPZ subdivisions share many of the features described for case NVA36, each 
subdivision has a distinct pattern of terminal innervation, particularly in the preoptic and caudal 
hypothalamus.  These differences are discussed at length below and highlighted in Fig. 2. 4.  Table 2.1 
contains a comprehensive, semiquantitative listing of terminal strength for efferent outputs of all four 
subparaventricular zone subregions. 
 
Ventromedial SPZ 
Of all four subregions, the vmSPZ showed the strongest outputs in the rostral and dorsal pathways.  
Ventral preoptic targets near the midline, including the organum vasculosum of the lamina terminalis, 
anteroventral periventricular nucleus, median preoptic nucleus, and ventromedial and ventrolateral  
preoptic nuclei were more richly innervated in case NVA84 than any other injection case confined to only 
one SPZ quadrant (Fig. 2.4E, Table 2.1).  Also, while other subregions sent at least as 
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Figure 2.4 Darkfield photomicrographs showing (A-D) injection sites (scalebar in A, 200µm) and 
(E-L) anterogradely labeled fibers and terminals (scalebar in E, 200µm) in cases of anterograde 
tracing from (A, E, I) vmSPZ, (B, F, J) vlSPZ, (C, G, K) dmSPZ, and (D, H, L) dlSPZ. 
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Table 2.1 Semiquantitative analysis of density of efferent projections from the four SPZ subregions 
 
 
 
Table 2.1: Projection density from subparaventricular zone subregions 
Region dlSPZ vlSPZ dmSPZ vmSPZ 
     
Basal Forebrain     
Lateral septum (predominantly ventral part) +++ ++ + +++ 
Bed nucleus of the stria terminalis +++(+) ++(+) +(+) +++ 
Parastrial nucleus +++ ++ + +++ 
Diagonal band of Broca ++ ++ (+) + 
Organum vasculosum of the lamina terminalis + 0 (+) +++ 
Substantia innominata ++ 0 0 0 
     
Hypothalamus     
Median pre-optic nucleus (MnPO) (+) (+) (+) +++ 
Medial pre-optic nucleus (MPO) ++ + (+) ++ 
Ventromedial pre-optic nucleus (VMPO) ++(+) + + ++++ 
Ventrolateral pre-optic area (VLPO) +(+) + + ++ 
Suprachiasmatic nucleus (SCN) + ++(+) +(+) +++(+) 
Ventromedial subparaventricular zone (vmSPZ) ++ ++(+) +++ n/a 
Ventrolateral subparaventricular zone (vlSPZ) ++++ n/a + ++++ 
Dorsolateral subparaventricular zone (dlSPZ) n/a +++ +(+) +++ 
Dorsomedial subparaventricular zone (dmSPZ) + + n/a +++ 
Anteroventral periventricular nucleus (AVPe) + + (+) +++ 
Anterior hypothalamic area (AHA) ++++ +++ + (+) +++ 
Retrochiasmatic area (RCh) ++(+) ++(+) +++ ++(+) 
Supraoptic nucleus (SON) (+) + (+) + 
Supraoptic decussation (Sox) +++ +(+) ++(+) +++ 
Supraoptic nucleus, retrochiasmatic part (SOR) +++ ++ ++(+) +++ 
Paraventricular nucleus of the hypothalamus (PVH) - anterior parvicellular +++ ++ ++(+) +++(+) 
Paraventricular nucleus of the hypothalamus (PVH) - middle + + ++ ++(+) 
Paraventricular nucleus of the hypothalamus (PVH) - lateral wing ++ ++ ++(+) +++ 
Dorsomedial nucleus of the hypothalamus (DMH) - anterior +++(+) +++ +(+) ++++ 
Dorsomedial nucleus of the hypothalamus (DMH) - compact and surrounding ++(+) ++ +(+) ++(+) 
Dorsomedial nucleus of the hypothalamus (DMH) - posterior ++ ++ +(+) +(+) 
Lateral hypothalamic area (LHA)  +(+) + ++ ++(+) 
Ventromedial nucleus of the hypothalamus (VMH) – dorsomedial +++++ + + +++ 
Ventromedial nucleus of the hypothalamus (VMH)  - central +++++ ++ (+) +(+) 
Ventromedial nucleus of the hypothalamus (VMH)  - ventrolateral ++++ +++ (+) +(+) 
Arcuate  nucleus of the hypothalamus – medial + (+) + ++(+) 
Arcuate  nucleus of the hypothalamus – lateral +++ ++ +(+) +++(+) 
Median eminence (ME) + + ++++ +++ 
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Table 2.1 – continued: Projection density from subparaventricular zone subregions 
    
Region dlSPZ vlSPZ dmSPZ vmSPZ 
Supramamillary +++ + (+) ++ 
Medial mamillary ++ + (+) (+) 
Mamillary body (edges) ++ ++ ++ +++ 
Tuberomamillary nucleus (TMN) ++(+) ++ + ++ 
Posterior hypothalamus ++(+) + (+) ++ 
     
Pons and brainstem     
Periacqueductal/central gray (PAG/CG) +++(+) +++(+) (+) +++ 
Ventral tegmental area (VTA) ++ + + + 
Substantia nigra (+) (+) (+) (+) 
Pre-coeruleus (+) n/a (+) + 
Locus coeruleus 0 n/a 0 (+) 
Parabrachial nucleus + n/a (+) +(+) 
     
Thalamus and habenula     
Paraventricular thalamus - anterior +++ ++(+) + ++++ 
Paraventricular thalamus - middle +++ + (+) ++++ 
Paraventricular thalamus posterior ++ + (+) +++ 
Habenula +(+) +(+) 0 (+) 
Paratenial thalamus ++ ++ (+) ++ 
Reuniens thalamus + ++ (+) ++(+) 
Intergeniculate leaflet (IGL) (+) +(+) 0 + 
Lateral geniculate nucleus of the thalamus (LGN) (+) (+) 0 +(+) 
Cortical structures     
Medial Amygdala ++ +(+) ++ ++ 
Central Amygdala + 0 + + 
     
Table 2.1 (continued) 
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strong a projection to the medial preoptic area as to the median preoptic nucleus (if not stronger), in case 
NVA 84 the median preoptic was preferentially innervated. 
 The vmSPZ also sent the richest projections dorsally into the anterior portion of the periventricular 
zone, to the rostral paraventricular thalamus and to the PVH, providing a particularly strong input to the 
anterior parvicellular division of this nucleus.  The contralateral input to paraventricular thalamus was 
remarkably strong, and contralateral innervation of the anterior PVH was also substantial. 
 The vmSPZ innervated the ipsilateral SCN and dmSPZ more richly than did any other SPZ 
subdivision (Fig. 2.4A, 2.5C).  It also provided fairly strong input to the ipsilateral vlSPZ, and an unusually 
robust projection to the contralateral vmSPZ, extending somewhat into the contralateral vlSPZ as well.  
The vmSPZ, more so than other SPZ subdivisions, innervated the adjacent AHA, LHA and DMH (Table 
2.1), in particular the DMH at its most rostral level and at the level of the compact subdivision (especially 
the medial third of these), although the density of boutons tapered off toward the more caudal aspect of 
the DMH.  Its projection to the VMH was not quite as strong as that from the dlSPZ (Fig. 2.4I, L), but 
showed a very distinct spatial pattern, with terminals preferentially innervating the dorsomedial VMH, 
dorsal and medial aspects of the VMH capsule, the central portion of the VMH, and the internuclear 
spaces in between the VMH and the DMH, arcuate nucleus, and periventricular zone (Fig. 2. 4I).  The 
vmSPZ also sent a significantly stronger projection to the median eminence (Fig. 2. 4I) than did the vlSPZ 
or dlSPZ, although, as described below, not as strong as that of the dmSPZ (Fig. 2.4L). 
 
Ventrolateral SPZ 
The vlSPZ had moderate to strong outflow in all four general pathways, and its distinct features 
were found in a few individual regions along each pathway.  In particular, unlike other SPZ subregions, 
the vlSPZ preferentially innervated the ventrolateral portion of the VMH (Fig.2. 4J), making it the only SPZ 
region whose VMH terminal field became more and more dense the further caudally it went. However, like  
most subregions, the vlSPZ provided stronger inputs to the capsule of the VMH (and internuclear spaces 
surrounding it) than to the body of the VMH.  The vlSPZ gave rise to a moderate projection to the rostral 
DMH with slightly less bias toward its medial aspect than seen with vmSPZ projections.  More caudally, 
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Figure 2.5 Schematic diagram illustrating estimated density of intra-SPZ projections based 
on anterograde tracing from the (A) dorsomedial, (B) dorsolateral, (C) ventromedial, and (D) 
ventrolateral SPZ. 
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the vlSPZ sent a particularly strong input to the central gray matter and ipsilateral premamillary region, but 
a fairly weak input to the supramamillary nucleus, and the weakest input to the median eminence of all 
four SPZ subdivisions.  The vlSPZ also strongly innervated the SCN, vmSPZ and dlSPZ, but only 
sparsely innervated the dmSPZ or any of these structures on the contralateral sides of the brain (Table 
2.1, Fig. 2.5).  Inputs to the amygdala were confined to the ipsilateral medial nucleus, showing no 
innervation of the central nucleus or the contralateral side. 
 
Dorsomedial SPZ 
The dmSPZ includes the portion of the periventricular nucleus which is richly innervated by the 
shell of the SCN (Fig. 2.1). Thus, it is to be expected that projections from this subregion share certain 
similarities with outputs from the periventricular zone in general. Our experiments demonstrated that this 
was indeed the case.   
 Unlike the other SPZ subregions, the dmSPZ did not have a particularly strong dorsal or caudal 
outflow.  Its caudal projection was for the most part sparse compared to other SPZ subregions, save for 
an intense input to a series of endocrine structures including the external lamina of the median eminence, 
a somewhat less intense projection through the internal lamina of the median eminence, and a moderate 
projection to the arcuate nucleus (Fig. 2.4K), suggesting that this may be a major site for circadian 
interactions with the endocrine system.  Projections to the tuberomamillary, premamillary, 
supramammilary and medial mamillary nuclei were much less intense, although the subset of fibers 
terminating along the edges of the mamillary body was as dense after dmSPZ injections as any SPZ 
subregion.  Across all four of our dmSPZ injection cases, the DMH received a more substantial input than 
the VMH, although neither terminal field was heavy (Fig. 2.4K).  Though not intense at any level, the 
innervation of the DMH by the dmSPZ was more consistent along the rostro-caudal extent of this nucleus 
than innervation coming from other SPZ domains.   
Inputs from the dmSPZ to the paraventricular thalamus were also sparse (especially to the more 
posterior portions of this nucleus).  In three of our four cases, we could not find labeled fibers in the lateral 
habenula.  The fourth case injection included a few labeled neurons in the dlSPZ and PVH, which we 
believe account for the very sparse habenular innervation seen.  More rostrally, there was a moderate 
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input to the anterior PVT, although not much innervation to the thalamic reuniens nucleus and even less 
to parataenial nucleus.  The parvicellular PVH did receive a substantial projection from the dmSPZ, which 
preferentially innervated the most rostral and caudal parvicellular subregions of this nucleus (Fig. 2.4C).  
Axons from the dmSPZ innervated the magnocellular PVH subdivision less intensely than its parvicellular 
components, but more extensively than did other SPZ subregions. 
 Anterior projections from the dmSPZ followed a pattern similar to the vlSPZ but with less 
intensity.  Interestingly, the projection curving anterolaterally into the stria terminalis gave rise to a 
projection to the amygdala which was as intense as that from other SPZ subregions and was more 
bilaterally robust.  Ipsilaterally, we saw a particularly widespread projection to the amygdala with fibers 
coursing through adjacent structures to terminate predominantly in the medial and central nuclei. 
 Finally the dmSPZ gave rise to a particularly heavy lateral projection, with many fibers following 
arcing trajectories into the lateral hypothalamus.  Some of these may have been from displaced 
vasopressin cells belonging to the PVH and sending their axons in this classic arcing trajectory, which 
turns back along the surface of the optic tract to run into the median eminence.  However, some axons 
innervated the supraoptic nucleus and others apparently entered the ventral supraoptic commissure.  
Axons in the lateral pathway were also followed back along the optic tract to the intergeniculate leaflet 
and lateral geniculate nucleus, as with other cases.  The dmSPZ sent a sizeable projection down to the 
vmSPZ and a stronger projection to the retrochiasmatic area than any other SPZ subregion. 
 
Dorsolateral SPZ 
The dlSPZ had robust outputs along all four pathways, but preferentially innervated certain 
structures along each outflow path.  Rostrally, the dlSPZ provided the densest input to the bed nucleus of 
the stria terminalis and substantia innominata (relative to other SPZ subregions).  There was also fairly 
strong input to the diagonal band nuclei and parastrial nucleus.  Via the dorsal outflow pathway, it 
provided a consistently strong input to all rostro-caudal levels of the PVT and a stronger input to the 
habenula than any other part of the SPZ.  Fibers in the lateral pathway gave rise to the most dense 
terminal field seen in the anterior hypothalamic area with less extension into the lateral hypothalamic 
area. 
54 

 Along the caudal pathway, dlSPZ neurons provided an exceptionally dense and uniform terminal 
field throughout the entire length of the VMH (Fig. 2.4, Table 2.1), most densely innervating the core of 
the dorsomedial subdivision of the VMH as well as the central subdivision and the internuclear capsular 
spaces surrounding the VMH. The projection to the DMH was of more modest intensity, distinctly favoring 
the rostral and medial third of this nucleus.  Axons continued caudally through and lateral to the arcuate 
nucleus, providing moderate numbers of labeled boutons in the median eminence and the caudal arcuate 
nucleus.  Of all subregions, the dlSPZ gave rise to the densest terminal fields in the tuberomammilary 
nucleus, posterior hypothalamus, and ventral tegmental area, with a strong input to the central gray 
matter as well. 
 The dlSPZ also provided local projections to the SCN and other SPZ subdivisions.  In particular, a 
heavy field of terminals and ramifications was seen in the ipsilateral vlSPZ, and vmSPZ.  While some 
terminals were also visible in the dmSPZ and SCN, these were much lower in number.   
 
Retrograde tracing confirms heterogeneity of efferents from different subparaventricular domains 
To confirm the validity of differences in anterograde projections to certain targets from the 
different SPZ subregions, we injected a retrograde tracer (CTb) into four of these target areas: the VLPO, 
VMH, DMH, and medial ARC (see Fig. 2.6 A, D and G, respectively). 
  
Ventrolateral preoptic afferents  
CTb was injected into the VLPO, filling the entire rostro-caudal extent of this nucleus, with 
densest staining in the ventral VLPO, and extending a bit medially into the ventromedial preoptic area.  
Retrograde tracing from this site most densely labeled cell bodies in the SCN shell and vmSPZ, but 
labeled no cells in the vlSPZ (see Fig. 2.6B).  A number of cells were labeled in the dorsal SPZ, mostly 
around the boundary between the dmSPZ and dlSPZ (Fig. 2.6C).  This is consistent with our anterograde 
tracing data suggesting that of the sites we analyzed, the vmSPZ is the largest contributor of projections 
the VLPO (see Fig. 2.4E, Table 2.1). 
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Figure 2.6 Brightfield photomicrographs showing (A, D, G, J) injection sites and retrogradely 
labeled cells (all middle and left panels) following CTb injection into the (A-C) ventrolateral pre-optic 
nucleus, (D-F) ventromedial hypothalamic nucleus, (G-I) dorsomedial hypothalamic nucleus, and (J-
L) arcuate nucleus 
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Figure 2.6 (continued) 
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Ventromedial hypothalamic nucleus afferents 
After an injection of CTb into the dorsomedial and central subdivisions of the VMH, but including 
parts of its capsule and a small amount of the ventrolateral VMH, the pattern of retrograde labeling seen 
in the SPZ was essentially as predicted by our anterograde tracing experiments (see Fig. 2 4D, L).  The 
dlSPZ, which sends by far the densest projection to the VMH, showed the highest numbers of 
retrogradely labeled SPZ neuron (Fig. 2.6E, F).  The retrogradely labeled neurons spilled over more 
laterally into other portions of the anterior hypothalamic area, so it may be more accurate to consider this 
an anterior hypothalamic projection, the medial portion of which is influenced by the SCN.  The ventral 
most (perisuprachiasmatic) portion of the vlSPZ (Fig. 2.6E) also showed a fairly high density of 
retrogradely labeled cells although a lower number of cells than that seen in the dlSPZ.  This pattern is 
consistent with our anterograde injection data showing that the vlSPZ projects predominantly to the 
ventral portion of the VMH capsule (Fig. 2.4J).  The retrogradely labeled neurons overlap into the 
midportion of the ventral SPZ (but not the exclusively medial zone), which explains why the projection to 
the VMH was also labeled  in some of our vmSPZ cases (e.g., Fig. 2.4I).  There was a striking absence of 
retrogradely labeled cells in the dmSPZ of this case, much as there is a striking lack of labeled 
anterograde projections in the VMH from this region (Fig. 2.4K). 
 
Dorsomedial hypothalamic nucleus afferents  
An injection of CTb was placed in the DMH (Fig. 2.6G), showing particularly intense filling in the 
medial third of the rostral DMH but filling the whole rostrocaudal extent of the nucleus.  Very light filling 
was also present in the periventricular zone anterior to the DMH, adjacent LHA at rostral DMH levels, and 
in small portions of the medial posterior arcuate nucleus that lie just caudal and ventral to the DMH.  This 
injection resulted in labeling of cell bodies along the most medial portion of the SPZ, including mostly cells 
in the vmSPZ and to some extent in the dmSPZ, with almost no labeling in the vlSPZ (Fig. 2.6H, I). It 
seems likely, based on this result, that the dlSPZ injection shown in Fig, 2.4D labeled axons in the DMH 
(Fig. 2.4L) (and which was even heavier in the most caudal portion of the DMH, see Table 2.1) by 
including some cells in the middle portion of the dorsal SPZ, along the medial edge of that injection. This 
result is consistent with retrograde labeling previously reported from our lab (Chou et al., 2003).   
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Arcuate nucleus afferents 
In this case (NVA 150) CTb was injected into the medial portion of the arcuate nucleus and 
continued dorsally to fill part of the adjacent periventricular zone (Fig. 2.6J).  The injection extended 
through the rostral and middle levels of the arcuate nucleus, tapering off at the posterior level (just caudal 
to the VMH).  CTb was seen in the adjacent periventricular zone just dorsal to the arcuate nucleus only at 
rostral levels of the injection.  Extremely faint CTb stain could be observed just rostral to this in the ventral 
periventricular zone at the level of the retrochiasmatic area.  In this case, there was an especially dense 
cluster of retrogradely labeled cells present in the caudal portion of the vmSPZ  (Fig. 2.6K, L), with 
scattered retrogradely labeled neurons in the remainder of the SPZ, consistent with our anterograde 
tracing (see Table 2.1). 
 
Discussion 
Previous work on inputs to the SPZ (Leak and Moore, 2001) had indicated a medial vs. lateral 
organization, while physiological evidence from lesion studies (Lu et al., 2001) suggested a dorsal vs. 
ventral organization.  Our systematic analysis of SPZ projections indicates that its outputs are organized 
along both of these lines, demonstrating that each of the four SPZ quadrants has a distinct set of targets 
(see below). 
In addition, the SPZ innervates several brain regions that have not previously been reported.  
Using expression of GFP induced by viral-vectors, we observe fibers and terminals from SPZ neurons in 
the dorsal raphe, locus coeruleus, pre-coeruleus region, lateral parabrachial nucleus and Barrington’s 
nucleus, (see Fig. 2.3, Table 2.1), none of which have been previously reported.  In addition to these 
novel targets in the hindbrain, we also observed a slightly different and more extensive pattern of 
innervation than previously described in the amygdala, habenula, and median eminence (see Fig. 2.3, 
Table 2.1).  We also observed that the four SPZ subdivisions project to each other and to the 
suprachiasmatic nucleus.  The dl,vl, and dm SPZ all seem to project strongly to vmSPZ, which in turn 
projects most strongly to the dm SPZ and SCN.  The vlSPZ and dlSPZ also project strongly to each other 
but don’t receive much vmSPZ input and get almost no dmSPZ input.  This connectivity allows for local 
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circuits to share information within the SPZ and suggests circadian outflow through it could be 
considerably more complex than previously described. 
  
Technical considerations 
The anterograde tracers used for this study, an adeno-associated viral vector expressing GFP 
(AAV-GFP) and in a few cases biotinylated dextran amine (BDA) have certain strengths and weaknesses 
that must be considered when interpreting the data.  BDA is an excellent anterograde tracer but carries a 
risk of retrograde uptake and transport anterogradely down collaterals of those same neurons.  This risk 
is strongly diminished when using an AAV-GFP from the serotype 2 group, as we did here.  AAV2-GFP 
retrogradely labels only one or two neurons per brain, hence collateral transport is unlikely to contribute 
substantially to the projections seen (Chamberlin et al., 1998). 
Although we use a combination of BDA and AAV-GFP injection cases to analyze differences in 
SPZ subregion projections, we fortunately we have injection cases with AAV-GFP (alone or in addition to 
BDA) for three out of four SPZ subregions, and are able to compare and verify that injections with the 
different tracers that are placed in similar sites give rise to extremely similar fiber and terminal fields 
elsewhere in the brain.  The only subregion for which we must rely on BDA anterograde tracing alone is 
the vlSPZ.  Fortunately, this is a subregion whose efferents have previously been reported using another 
tracer with less risk for retrograde uptake (PHAL), and our findings match the previous reports of vlSPZ 
efferent targets (Canteras et al., 2011). We also examined our own AAV-GFP cases for labeled neuronal 
cell bodies more than 1,000 µm from the injection site, and found fewer than one per brain. 
An important advantage of tracing with AAV-GFP is that once neurons take up this vector, GFP 
expression within them persists in the brain indefinitely, (as oppsed to BDA or PHAL which degrade 
around 4 weeks’ time), and this makes it possible to ensure filling of extrememly distal fibers and boutons 
by allowing many weeks or months for the AAV-GFP to fill the neurons in  a long range pathway.   This 
may explain why we were able to visualize distal SPZ targets including the the dorsal raphe, locus 
coeruleus, pre-coeruleus region, lateral parabrachial nucleus and Barrington’s nucleus, when previous 
tracing studies did not.  It is worth noting that injection cases in which we saw labelling in these regions 
were all cases where eight to nine weeks elapsed between AAV-GFP injection and perfusion, and they 
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typically involved more than one SPZ subdivision.   Even though we focus much of our analysis in this 
study on assessing which SPZ subdivisions provide the most significant input to certain targets, it bears 
mention that SPZ fibers and terminals in distal sites like Barrington’s nucleus may only be seen after large 
injections of AAV-GFP covering multiple SPZ subregions, suggesting that in some projections there is no 
SPZ subregion acting as the dominant relay channel. 
Furthermore, though we make an effort to estimate them, it is not possible to make rigorous 
quantitative comparisons of terminal density across two injection cases given the fact that each injection 
fills a different number and distribution of neuronal cell bodies.  However, semi-quantitative comparison 
across several different cases of injections placed in adjacent/overlapping regions can still provide 
information regarding differential innervation of target sites by adjacent SPZ subdivisions.  Furthermore, 
retrograde tracing from targets of the SPZ can resolve the ambiguity in interpretation of anterograde 
tracing findings.  We have relied heavily on case-to-case comparison and complementary retrograde 
tracing in selected terminal fields to clarify the differences between projections from different SPZ 
subdivisions. 
 
Functional implications of SPZ connectivity 
Many of the novel SPZ targets we observed receive the bulk of their input from the vmSPZ and 
are thought to play a role in sleep/wake regulation, namely the parabrachial nucleus, locus coeruleus, 
pre-coeruleus region, and dorsal raphe nuclei (Saper et al., 2010).  These observations are consistent 
with earlier studies showing that the ventral SPZ plays a particularly important role in the circadian 
modulation of sleep.  The vmSPZ also projects to the lateral hypothalamic area, median preoptic nucleus, 
VLPO and the anterior and compact levels of the DMH (see Table 2.1).  In the case of the VLPO and 
DMH, we have been able to confirm via retrograde tracing that their SPZ afferents come mostly from the 
ventromedial quadrant (see Fig. 2.6). While all the sites listed above play significant roles in sleep-wake 
regulation, only lesions of the DMH specifically disrupt the circadian timing of sleep and wake throughout 
the day (Chou et al., 2003), suggesting the vmSPZ projection to this level of the DMH may carry particular 
functional relevance in circadian modulation of behavioral state. 
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Lesions of the DMH have also been shown to disrupt circadian rhythms in adrenal corticosteroid 
secretion and feeding, which may also depend on intact vmSPZ fibers relaying SCN clock input to this 
portion of the DMH.  We also show both via anterograde and retrograde tracing that the vmSPZ is the 
main contributor of SPZ inputs to the arcuate nucleus, particularly its medial subdivision (and to the 
periventricular zone just dorsal to it) (Table 2.1, Fig. 2.6).  These sites contain neurons mediating 
prolactin release (Moore, 1987), as well as feeding behavior and energy expenditure, and their responses 
to leptin and ghrelin (Cone, 2005; Krashes et al., 2011; Kong et al., 2012).   
There is also evidence that SPZ transections disrupt diurnal rhythms in reproductive hormones 
(Watts et al., 1989).  Knife cuts through the SPZ were reported to blunt diurnal rhythms of both prolactin 
and luteinizing hormone (Watts et al., 1989).  Prolactin release is regulated by periventricular and arcuate 
dopamine neurons, which receive major inputs from the vmSPZ. The anteroventral periventricular nucleus 
(AVPe) is thought to regulate leutenizing hormone (LH) release (Robertson et al., 2009).  Circadian 
regulation of LH release is dependent on ipsilateral neural outflow from the shell region of the SCN to the 
AVPe (de la Iglesia et al., 2003; de la Iglesia and Schwartz, 2006; Smarr et al., 2012) , although direct 
projections from the SCN shell to the AVPe are quite sparse.  As the vmSPZ both receives a strong input 
from the SCN shell and sends a robust projection to AVPe, it is likely to be a critical relay in this pathway.   
The vmSPZ may affect circadian regulation of other endocrine rhythms together with the dmSPZ.  Both of 
these subregions give rise to an impressively dense terminal field in the external lamina and to a fiber 
bundle in the internal lamina (dorsal third) of the median eminence bilaterally.  This makes the medial 
SPZ well positioned to modulate the release of pituitary hormones.   
It thus seems likely that the medial SPZ may be involved in endocrine rhythm regulation, while 
the vmSPZ is particularly involved in circadian regulation of sleep and wakefulness.  The lateral SPZ 
subdivisions, on the other hand, may act more as an entry point for non-SCN inputs to these circadian 
outflow circuits, with more limited roles in outflow. 
The dlSPZ has strong reciprocal connections with the VMH, which may have a variety of 
physiological implications.  The dlSPZ both receives a strong input from leptin-sensitive neurons in the 
dorsomedial VMH (Elmquist et al., 1998) sends a robust projection to that region (Table 2.1, Fig. 2.4).   
These dmVMH neurons are implicated in energy homeostasis and maintenance of plasma glucose levels 
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(Tong et al., 2007; Hawke et al., 2009; Xu et al., 2010).  The dlSPZ also projects strongly to the vmSPZ 
and vlSPZ, perhaps relaying satiety/energy balance signals, and has a particularly impressive projection 
to the ventrolateral VMH, an area implicated in control of aggression and reproductive behavior (Lin et al., 
2011).   
The vlSPZ receives the largest share of the retinal (see Fig. 2.1, (Gooley et al., 2003; Canteras et 
al., 2011) and IGL (Moga and Moore, 1997) input to the SPZ, an area implicated in exercise mediated 
and photic circadian phase resetting (Harrington and Rusak, 1986; Harrington, 1997).  The vlSPZ is also 
the subdivision projecting most strongly to the IGL, vmSPZ, and dlSPZ, making it well positioned to 
integrate photic and activity-based entrainment cues into circadian outflow circuitry downstream of the 
SCN. Previous studies have suggested that light masking of various rhythms can still occur following 
damage to the SCN (Redlin and Mrosovsky, 1999) or knife cuts between the SCN and SPZ (Watts et al., 
1989), but not following SCN lesions which extend into the adjacent ventral subparaventricular zone (Li et 
al., 2005). These findings suggest that light masking of activity could be mediated through direct or 
relayed retinal inputs to the vlSPZ and its downstream outputs.  Studies of nocturnal vs. rodents also 
indicate that retinal innervation of the vlSPZ (or lack thereof) between postnatal day 8 and 15 coincides 
with the development of consolidated night-time vs. day time wakefulness, respectively, and may explain 
how an rodent’s (or any mammal’s) active phase is determined (Todd et al., 2012). 
The configuration and development of neural connections between the SPZ and other brain 
regions can surely explain much about a mammal’s phase angle of entrainment and daily temporal 
patterns, as well as adaptability to new or alternate schedules.  While these neural connections and 
default schedules are typically formed early in life, e.g. by postnatal day 15 in rats (Blumberg et al., 2005; 
Gall et al., 2008), it is   not uncommon for adult mammals to change their active phase in response to 
environmental pressures or external incentives (Saper et al., 2005; Gattermann et al., 2008; Cohen et al., 
2010).  It is likely that changes in the way the SPZ receives, processes and communicates information to 
other parts of the central nervous system underlie adaptation to new schedules as well as the 
development of circadian and diurnal rhythms early in life. 
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Chapter 3: Role of glutamatergic neurons in the dorsomedial hypothalamic nucleus in circadian 
organization of behavior 
 
 
 
Abstract 
The dorsomedial nucleus of the hypothalamus (DMH) has been implicated in a wide array of 
physiological and behavioral regulatory functions, including modulation of endocrine output, activity and 
wakefulness, ingestive behaviors, thermogenesis, as well as the circadian regulation of many of these 
functions.  Cell-specific DMH lesions lower the amplitude of circadian rhythms in locomotor activity, wake-
sleep, food intake and corticosteroid release (but not body temperature), and lead to decreased activity, 
wakefulness, plasma cortisol and core body temperature over the whole circadian day (Chou et al., 
2003).  The DMH is a heterogeneous brain region, and it is unclear which neurotransmitters and 
projections mediate these various functions.  Most neurons in the DMH are either glutamatergic or 
GABAergic.  Experimental evidence implicates glutamatergic projections from the dorsal hypothalamic 
area (DHA)  and adjacent DMH to the raphe pallidus in thermoregulation (Yoshida et al., 2009; Morrison 
et al., 2012) and glutamatergic projections from the DMH to the lateral hypothalamic area, as well as 
GABAergic projections from the DMH to the ventrolateral preoptic nucleus in modulation of temporal 
patterns in behavioral state (Chou et al., 2003).  To test the importance of glutamatergic efferents of the 
DMH for shaping circadian rhythms, we employed mice in which the second exon of the vesicular 
glutamate transporter 2 (VGlut2) gene was flanked by loxP sites.  After stereotaxically injecting an adeno-
associated viral vector expressing Cre recombinase into the DMH, neurons in the DMH expressed Cre 
and showed loss of VGlut2, which is necessary for loading glutamate into their synaptic vesicles.  Mice in 
which the glutamatergic transmission by DMH neurons had been deleted showed many of the same 
features as rats with cell-specific DMH lesions.  The amplitude of the circadian and diurnal rhythm in 
locomotor activity rhythm in mice with VGlut2 deletion in the DMH was reduced to roughly 50% that of 
control animals.  Average locomotor activity for the day was reduced to approximately 75% that of 
controls. Average body temperature was lowered by 0.3 ºC though the amplitude of circadian and diurnal 
rhythms in body temperature was not significantly affected.  As with cell-specific lesions to the DMH, the 
deletion of VGlut2 from the DMH significantly lowered the amplitude of circadian rhythms of 
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corticosteroids. The above findings suggest that glutamatergic neurons in the DMH are critical for normal, 
healthy rhythms in activity and corticosteroid release and the DMH/DHA is necessary for maintaining 
normal core body temperature throughout the day.  To selectively investigate glutamatergic efferent 
projections from the DMH that could underlie these effects, we performed a conditional tracing 
experiment by injecting a viral vector expressing GFP downstream from a loxP-flanked stop codon into 
the DMH of a VGlut2-Cre mouse.  We observed fairly robust glutamatergic projections from the DMH to 
the lateral hypothalamic area and from the DMH/DHA to the raphe pallidus nucleus which may be directly 
involved in regulation of daily rhythms and levels of locomotor activity, and in maintenance of normal core 
body temperature, respectively. 
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Introduction 
The dorsomedial nucleus of the hypothalamus (DMH) is involved in regulation of many different 
autonomic, endocrine and behavioral parameters and plays an important role in relaying information from 
the circadian clock in the suprachiasmatic nucleus (SCN) to the rest of the brain.  It is thought to integrate 
circadian inputs with signals from other sources (e.g., food availability, stress, etc.) to coordinate daily 
patterns of behavior and physiology.  It receives direct synaptic input from both the SCN (Watts and 
Swanson, 1987; Watts et al., 1987; Abrahamson and Moore, 2001) and the subparaventricular zone 
(Watts and Swanson, 1987; Thompson and Swanson, 1998; Chou et al., 2003).  It also receives inputs 
from sites including the median preoptic nucleus, likely relaying information on body or brain temperature; 
from the parabrachial and arcuate nuclei, likely conveying information about hunger and satiety; and from 
catecholaminergic groups in the brainstem, which are strongly implicated in stimulation of behavior and 
endocrine responses to stress, i.e. increased locomotion and a rise in corticosterone release (Thompson 
and Swanson, 1998).  Notably, neurons in the DMH itself are sensitive to hunger and satiety signals; a 
subpopulation of them expresses leptin receptors and shows immediate early gene activation following 
leptin infusion (Elmquist et al., 1998; Elmquist et al., 2005; Gautron et al., 2010). 
In rats, cell-specific DMH lesions decrease the amplitude of circadian rhythms in wake-sleep, 
locomotor activity, food intake and corticosteroid release (but not body temperature), and lead to 
decreased baseline wakefulness, activity, plasma cortisol and core body temperature (Chou et al., 2003).  
Based on histological evidence available in rat, it has been hypothesized that the effects seen on 
wakefulness could depend on a predominantly glutamatergic projection to the wake-consolidating lateral 
hypothalamic area (LHA), and a predominantly GABAergic projection to the sleep-promoting ventrolateral 
pre-optic nucleus (VLPO), but this has not been tested.  Evidence from rat studies also suggests that a 
glutamatergic projection to the raphe pallidus (RPa) from a very specific subpopulation of dorsal 
hypothalamic area neurons and adjacent DMH neurons (DMH/DHA) may be responsible for the effects 
seen on body temperature. 
 These DMH/DHA neurons, which are implicated in mediating body temperature and heart rate 
regulation (Dimicco and Zaretsky, 2007), sit along the dorsal border of the DMH at the level where the 
mammillothalamic tract rises above the dorsal edge of the third ventricle.  A number of physiological 
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studies suggest that this group of neurons drives brown adipose tissue thermogenesis via an excitatory 
projection to pre-sympathetic neurons in the raphe pallidus (RPa) in the rostral medulla (Morrison et al., 
2012).  Retrograde tracing from the RPa coupled with cold-induced immediate early gene labeling in rat 
pinpoints a region in the DMH/DHA at the level of the compact zone of the DMH (Yoshida et al., 2009).   
No stimulation/inhibition of this region or retrograde tracing from RPA has been reported in mouse. 
 While histological evidence from the rat model can provide useful hypotheses regarding which 
DMH projections underlie which physiological function, and what neurotransmitters they release, these 
questions are much more readily testable by employing genetic manipulations in a mouse model.  Here, 
we employed such a model to specifically study the role of glutamatergic DMH neurons in regulation of 
basal levels and daily rhythms of locomotor activity, body temperature, corticosterone output and nutrient 
intake.  Since glutamatergic signaling significantly affects synapse and neural circuit formation during 
brain development (Cline, 2001), we allowed mice to develop normally and introduced viral vectors to 
disrupt glutamatergic signaling in the DMH only in mice over  9 weeks old. 
Because light has been shown to have acute effects on locomotor activity, body temperature and 
corticosterone output (Morin, 2013), we measured both circadian (free-running) and diurnal (light-
entrained) rhythms of these functions in constant darkness (DD) or a 12:12hour light:dark cycle (LD), 
respectively.  This allowed us to also investigate whether excitatory DMH neurons are a part of the neural 
circuit by which light directly affects the above functions.  
 
Methods 
Animals and housing 
All protocols used in this study were approved by the Harvard University or Beth Israel 
Deaconess Medical Center Animal Care and Use Committees and conform to the regulations detailed in 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals.   
We used a line of VGlut2 conditional knock-out mice (VGlut2 flox/flox) in which exon 2 of the VGlut2 
gene is flanked by loxP sites.  The VGlut2 flox/flox mice were generated and validated by Tong and Lowell. 
and shown to lose the ability to release glutamate synaptically from  VGlut2-positive neurons that express 
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Cre-recombinase  (Tong et al., 2007).  In our study, homozygous VGlut2 flox/flox males (n=27) were used 
for physiological experiments.   
Prior to physiological recordings, mice were group housed, up to 5 per cage, in a 12:12h 
light:dark cycle, with ad libitum access to food (Purina formulab chow diet, irradiated, 5008C33) and 
water.  For physiological experiments mice were singly housed and exposed to 12:12h light:dark cycle for 
some portions of the study and in constant darkness for others, with ad libitum access to chow and water 
or to a liquid diet (Osmolite 1 Cal/ml isotonic formula, Ross Nutrition).  Exclusively male mice were used 
for both tracing and physiological experiments. 
 
Viral vectors and experimental design 
Several different adeno-associated viral vectors (AAVs) were used to drive expression of Cre-
recombinase, green fluorescent protein (GFP) or both in transduced cells. 
In one cohort, VGlut2 flox/flox mice (n=5) received injections into the DMH of an AAV containing the 
gene for Cre-recombinase on a cytomegalovirus promoter (AAV-Cre),(serotype 10, titer: 1.13 x 1013 
genome copies (GC)/ml, with yield of 7.11 x 1012 GC/ml).  The effectiveness and specificity of VGlut2 
exon 2 deletion by injecting this AAV into VGlut2 flox/flox mice has been demonstrated previously (Krenzer 
et al., 2011).  For the control experiment, age-matched VGlut2 flox/flox mice (n=5) had injections of an AAV 
containing the gene for Aquaphora GFP (humanized UF5 form) on a cytomegalovirus promoter (AAV-
GFP), (serotype 8, titer: 6x106 GC/ml) containing the same cassette as described in (Chamberlin et al., 
1998).   
In a second cohort, VGlut2 deletion from the DMH was achieved via injection of an AAV 
containing both the genes for Cre recombinase and GFP (AAV-GFP-ires-Cre) into VGlut2 flox/flox mice 
(n=7).  This vector was produced by the Harvard Gene Therapy Initiative, Boston by Dr. Jeng-Shin Lee 
(serotype 8, titer: 8.1 x 1012 GC/ml).  Effectiveness and specificity of VGlut2 exon 2 deletion by injecting 
this AAV into VGlut2 flox/flox mice has also been demonstrated previously by our group (Kaur et al., 2013).  
Again, the control group consisted of age-matched VGlut2 flox/flox mice (n=10) with injections of AAV-GFP 
into the DMH.   
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As a control to ensure that effects on physiology seen with Cre expression in VGlut2 flox/flox mice 
are indeed due to VGlut2 exon2 excision and not nonspecific effects of transduction by the vector, a 
cohort of wild-type mice (n=6) received AAV-GFP-ires-Cre injections into the DMH. 
 
Brain injections 
Mice were anesthetized with an intraperitoneal injection of ketamine-xylazine (100mg/kg 
ketamine, 10mg/kg xylazine) and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, 
CA).  Under aseptic conditions the brain was exposed and an injection of viral vector delivered through a 
glass pipette using an air pressure injection system.  The incision was closed with suture and the animals 
given subcutaneous injections of the analgesic meloxicam (0.2 mg, daily for two days).  To delete VGlut2 
exon 2 for physiological experiments, bilateral injections of 50-60 nl of AAV-Cre or 170-200 nl of AAV-
GFP-ires-Cre were placed into the DMH (AP -1.75;  DV -5.0; RL ±0.4) of VGlut2 flox/flox mice.  For control 
experiments, 50-70 nl of AAV-GFP were injected bilaterally into the same location in VGlut2 flox/flox mice, or 
170-200 nl of AAV-GFP-ires-Cre were injected bilaterally using the same coordinates in wild type mice.  
Three to four weeks were allowed for postoperative recovery and for expression of the Cre and/or GFP 
genes encoded in the viral vectors. 
 
Telemetric recording 
Body temperature and spontaneous home cage locomotor activity were measured using 
radiofrequency biotelemetry transmitters (TA10TA-F20; Data Sciences International).  These were 
implanted intraperitoneally using aseptic technique in the same session of anesthesia during which brain 
injections were performed.  Animals were allowed 3-4 weeks of time for postoperative recovery and for 
the viral vectors to deliver and express Cre and or GFP genes within neurons.  Spontaneous home cage 
locomotor activity and body temperature were then recorded from mice entrained to a 12:12h light:dark 
cycle (LD) for at least 5 days and from mice free-running in constant darkness (DD) for at least 10 days.  
During recordings, mice remained in their home cages with ad libitum access to chow and water.  Their 
cages were housed atop DSI telemetry receivers connected to a microcomputer acquisition system.  
Cages and receivers were inside light-tight, fully ventilated cabinets for the duration of the recordings.  
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Ambient temperature inside the recording cabinets was maintained at 22±1ºC, and light:dark cycles were 
controlled via programmable switch timers.  Core body temperature was measured every 5 minutes and 
locomotor activity was recorded in 5 minute bins. 
 
Rotarod test 
To check for motor control deficits in mice with VGlu2 deletion in the DMH, these animals and 
AAV-GFP-injected controls from the same cohort were trained and tested for performance on an 
accelerating rotarod (Ugo Basile, mouse rota-rod).  Training consisted of sessions where each animal 
was given 5 trials on a rotating beam 6 inches above a platform which accelerated from 2-40 rpm over 
4min., with 5min. rest periods in between trials.  Testing sessions consisted of 7 such trials, where 
performance was the average amount of time a given mouse was able to able to run on the beam before 
falling to the platform below per trial.  To control for circadian effects on performance, mice had three 
training sessions from 4-6pm on three consecutive days, followed by two testing sessions from 4-6pm on 
the following two days.  All mice were fully entrained to a 12:12 light:dark cycle with lights-off at 7pm 
during training and testing.   
 
Measurement for liquid diet intake and corticosterone rhythm 
Since corticosterone levels respond rapidly to stress, repeated measurement of this hormone 
must be done using a minimally invasive approach which is not stressful to the subject.  For this reason 
we opted to measure urinary corticosterone from samples collected every 4 hours over the course of a 
day with the aid of metabolic cages (Tecniplast, West Chester, PA), starting after 24 hours of habituation 
to the metabolic cages.  This was done both in mice that were entrained to a 12:12h LD cycle and in mice 
that were free-running in constant darkness (DD) for at least 10 days prior to urine sample collection.  To 
ensure that a large enough volume of urine could be collected at each time point, mice were maintained 
on a liquid diet (Osmolite 1 Cal/ml isotonic formula, Ross Nutrition) for the duration of this experiment.  
This diet is isotonic, and mice do not lose weight after one week of access to exclusively this diet.  Bottles 
of liquid diet were changed every 12 hours to minimize bacterial growth.  Liquid diet intake was measured 
by recording drinking bottle weight every 4 hours as urine samples were being collected.  To allow for 
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habituation, mice in their home cages were switched from a chow and water diet to liquid diet 4 days prior 
to the start of urine sample collection and were then transferred from their home cages to metabolic 
cages 24 hours prior to the start of sample collection.  To measure phase of free-running animals reliably, 
body temperature and locomotor activity rhythms were recorded for at least 8 days before habituation to 
metabolic cages.  All mice run together in DD showed a sharp rise in body temperature within 15 minutes 
of one another, just before the onset of the subjective dark period.  Corticosterone concentration was 
measured using an ELISA assay kit (Enzo Life Sciences), and for each sample, concentration measured 
was multiplied by the volume of sample collected to calculate amount excreted per 4-hour interval. 
 
Tissue Preparation 
After physiological and behavioral experiments were completed mice were anesthetized with 
chloral hydrate (10 mg/kg) and underwent transcardial perfusion with 0.9% saline followed by 10% neutral 
buffered formalin (Sigma).  Brains were removed and postfixed for approximately 3 hours in formalin then 
allowed to equilibrate for at least 12 hours in a 20% sucrose solution in phosphate buffered saline with 
0.01% sodium azide.  Brains were subsequently sectioned at 30 ȝm on a freezing microtome into four 
series. 
 
Immunohistochemistry 
Immunohistochemistry was performed on floating sections following a protocol described in 
previous publications (Bruinstroop et al., 2011), and as described in thesis chapter 2.  Sections were 
rinsed at least three times for 5-10 minutes in 0.1M phosphate buffered saline (PBS), pH 7.4, for 1 hour, 
then were incubated in 0.3% hydrogen peroxide to block endogenous peroxidase activity.  Following at 
least three more rinses in PBS, sections were incubated for at least 16 hours in a solution containing the 
appropriate primary antibody (see below) in PBS containing 0.3% Triton X-100 and 0.01% sodium azide.  
Sections were then rinsed at least three more times in PBS before a one-hour incubation in a 
corresponding secondary antibody (see below for specific information), rinsed three more times in PBS, 
and then incubated for 60-90 minutes in an avidin-biotin complex solution (Elite ABC, Vector 
Laboratories).  After three more PBS rinses, the tissue was moved to a solution containing 1% 3,3’-
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diaminobenzidine (DAB) and reacted with 0.01% hydrogen peroxide to visualize the sites containing 
antigen in the tissue.  Once the desired staining intensity was reached, this reaction was quenched with 
several rinses of the tissue in a PBS solution containing 0.01% sodium azide.  Sections were then 
mounted onto gelatin coated glass slides and allowed to dry overnight at room temperature.  This was 
followed in some cases by silver-gold enhancement and/or counterstaining with thionin.  Silver-gold 
enhancement consisted of a 30 - 45 minute incubation of desalinated slides in 1% silver nitrate solution at 
56 qC, followed by three rinses with water, a 10-20 minute incubation in 0.1% gold chloride, three more 
rinses and a brief treatment with 5% sodium thiosulfate solution until the tissue reaches the desired 
background level.  All slides were rinsed in distilled water before they were dehydrated in graded alcohols 
then cleared in xylene for at least 2 hours and cover-slipped with Permaslip medium (Alban Scientific, St. 
Louis, MO).  Counterstained sections were incubated briefly in thionin solution and differentiated in acid 
alcohol prior to dehydration. 
Neurons labeled with the AAV-GFP or AAV-GFP-ires-Cre vectors were visualized with a primary 
antibody against GFP raised in rabbit against Aquaphora GFP protein (Molecular probes/Invitrogen ca# 
A6455 Lot# 771568), used at a concentration of 1:20,000. This was followed by rinses and incubation 
with a biotinylated donkey anti-rabbit secondary (Jackson Immunoresearch Laboratories) used at a 
1:1,000 dilution.  This antibody did not label any neurons above background level in tissue from 
uninjected animals or AAV-Cre-injected animals. 
Neurons transduced with the AAV-Cre vector were identified via immunolabeling for Cre protein 
with a monoclonal primary antibody raised in mouse against the Cre recombinase (aa 77 and 343) fusion 
protein (clone 2D8), (Millipore/Chemicon cat# MAB3120 Lot# LV1414478) used at a dilution of 1:20,000.  
This antibody does not label any neurons above background level in tissue from un-injected animals or 
AAV-GFP-injected animals. 
  
 
Microscopy and photography 
Slides were examined and photomicrographs were acquired with a Zeiss Axioplan 2 microscope 
with a 1.5 megapixel color Evolution MP camera (MediaCybernetics, Bethesda, MD) using Axiovision 
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software.  The images were then processed with Adobe Photoshop software to optimize the 
brightness/contrast. 
 
Data analysis 
Lesion assessment 
For each case, whether a VGlut2 flox/flox mouse injected with AAV-Cre (whose brain tissue was 
subsequently immunolabeled for Cre recombinase) or a VGlut2 flox/flox mouse injected with AAV-GFP-ires-
Cre (whose brain tissue was subsequently immunolabeled for GFP), lesion extent was quantified by 
mapping the area of transduced neurons within the DMH (at two rostrocaudal levels: AP – 1.7 and AP – 
1.9) and DMH/DHA (at AP – 1.7).  Locomotor activity and corticosterone data were analyzed using area 
of the two DMH levels covered as the criterion for a successful lesion case, while temperature data was 
analyzed using area of DMH/DHA at AP – 1.7 covered as the criterion.  This approach was used because 
staining for Cre in AAV-Cre-injected mouse brains labels only transduced cell nuclei in a clearly 
distinguishable way (see Fig 3.1 A-C).  However, the AAV-GFP-ires-Cre does not produce Cre 
recombinase at sufficiently high levels to cause reliable dense staining.  (This is not a problem, as it takes 
only one Cre molecule per cell to cause the recombination event, so even very low levels of expression 
are sufficient to cause the deletion of the Vglut2 exon 2, as shown in Kaur et al., 2013).  In these cases, 
we instead stained for GFP, which labels cell bodies and processes creating much more spatial overlap 
of labeled structures, and making it more difficult to distinguish individual GFP-labeled neurons and hence 
to quantify the actual number of transduced neurons (see Fig. 3.1 D-C), (see Technical Considerations in 
Discussion).  However, assessment at high magnification suggested that the two viral vectors had similar 
infection efficiency within the DMH.  Thus in order to apply identical techniques for quantification of the 
extent of the genetic deletions across the two cohorts, each injection site (i.e. the region of transduced 
cells) was mapped onto a brain template at the appropriate rostrocaudal level using a camera lucida 
(Leitz Wetzlar).  These drawings were digitized using a Wacom Intuos PTK-1240 tablet and Adobe 
Illustrator Software, and the percentage of DMH area covered by transduced cells was quantified using 
ImageJ software (NIH). Only cases in which at least 50% of the DMH area (across the two rostrocaudal 
levels) was covered on each side of the brain were considered successful bilateral injections and used for  
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Figure 3.1 A series of photomicrographs to illustrate two injection sites in the brain of (A-C) one AAV-Cre 
injected case (NV42, with approximately 96% coverage), stained for Cre-recombinase, and (D-F) one 
AAV-GFP-ires-Cre injected case (NV138 with approximately76% coverage), stained for GFP.  Panels G-I 
show reference sections at corresponding rostro-caudal levels from the Allen Mouse Brain Atlas (Lein et 
al., 2007).  The DMH at each level is outlined in black. 
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physiological analysis.  This 50% minimum cutoff was employed to avoid potential confounding effects of 
highly asymmetrical injections, and average coverage per side in successful cases was well above 50% 
(see results).  All injection mapping was done blind with respect to case number or physiology of the 
animal in question.  Calculation of the phase, amplitude or baseline of each rhythm was done blind to the 
case number or lesion extent of each animal. 
 
Analysis of behavioral and physiological output measures  
For all output measures, amplitude of circadian or diurnal oscillation was calculated as circadian 
index (CI), using the following formula:  CI = (meannight - meanday)/mean24h, normalized to 100% for the 
control group, where meannight is the average over the subjective dark period, meanday is the average over 
the subjective light period, and mean24h is the average over the entire subjective day.  For mice in DD, the 
free-running period was calculated using a chi-squared periodogram, and timing of subjective night and 
day were assessed visually on raster plots, using Clocklab software (Actimetrics, Wilmette, IL). 
Telemetric recordings of body temperature required special consideration, as there were occasionally 
spurious readings due to electrical noise (usually with a single out of range reading) and in some cases 
progressive shifts in the baseline of temperature readings representing loss of proper temperature 
calibration approaching the end of the battery life of the transmitter.  Temperature recordings from five 
animals were discarded from analysis for the latter reason.  To correct for the former, we created a 
filtering application which identified temperature readings above 40ºC, below 30ºC, or readings that were 
more than 2ºC different from immediately flanking readings (taken only 5 minutes before/after), and 
replaced them with NaN placeholders.  This was done prior to any other analysis of body temperature 
recordings. 
 
Statistics 
Data is graphed and reported as mean±SEM.  Linear mixed models were used to assess the effects of 
VGlut2 loss in the DMH on the CI and absolute levels of various physiological and behavioral parameters 
measured (locomotor activity, body temperature, urinary corticosterone levels, urine volume, and liquid 
diet intake).  For these tests, light cycle (entrained vs. free-running conditions), lesion condition (control 
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vs. VGlut2 loss in the DMH) and the interaction between the two were treated as fixed factors, while the 
effect of individual subject was treated as random.  Linear mixed models were also used to check for 
differences in body temperature and activity level between the active and inactive period in mice with 
VGlut2 deletion in the DMH and controls in both free-running and entrained conditions.  Here, (subjective) 
light vs. dark and lesion condition were treated as fixed factors and the effect of individual subject was 
treated as random.  Paired t-tests were used to check for differences in the CI and absolute levels of 
locomotor activity and body temperature in wild type controls before and after they were injected with Cre-
expressing viral vector.  The effect of VGlut2 loss in the DMH on rotarod performance was estimated 
using an unpaired student’s t-test (with equal variances not assumed).   All statistical tests were 
performed using SPSS 21 (IBM, SPSS, Chicago, IL, USA).  The alpha value was set to P < 0.05 (two 
tailed) for main effects, and P < 0.10 (two tailed) for interaction effects. 
 
Results 
Twelve VGlut2flox/flox mice had injections of Cre-expressing vectors placed successfully, bilaterally 
in the DMH, and fifteen VGlut2flox/flox mice served as controls, with bilateral injections of vector expressing 
only GFP into the same site.  These mice came from two cohorts, with two different Cre-expressing 
vectors used: n=5 mice had AAV-Cre injected into the DMH (see Fig. 3.1A) and these had locomotor 
activity and body temperature measured in parallel with n=5 AAV-GFP control mice; n=7 mice had AAV-
GFP-ires-Cre injected into the DMH (see Fig. 3.1B) and these mice had locomotor activity, body 
temperature, urinary corticosterone output and liquid diet intake measured in parallel with n=10 AAV-
GFP-injected control mice.  Here we show data from the two cohorts pooled (with locomotor activity 
counts and circadian indices of activity and temperature normalized to the appropriate controls).  Effects 
seen within each cohort independently are extremely similar.  Among the n=12 mice with bilateral VGlut2 
deletion in the DMH whose activity data was compared to controls, average DMH area covered by Cre-
transduced cells was 77% per side.  Temperature recordings from n=13 controls and n=9 mice with 
VGlut2 deletion in the DMH were usable for analysis.  These 9 mice had on average 90% DMH/DHA 
coverage per side.  Reliable, phase-aligned liquid diet intake and corticosterone output data was available 
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from n=5 control mice and n=5 mice with VGlut2 deletion in the DMH (all from the AAV-GFP-ires-Cre 
cohort) with on average 72% DMH coverage per side. 
 
Loss of VGlut2 expression in the DMH disrupts daily locomotor activity rhythms and levels and 
lowers body temperature 
Raster plots showing double-plotted temperature and activity in a representative control mouse 
(KR18) (Fig. 3.2A, C respectively) and representative mouse with VGlut2 deletion from the DMH (NV143) 
(Fig 3.2B, D), reveal that the latter had a disruption in daily locomotor activity patterns in both entrained 
(LD, days 1-10) and free-running (DD, day 11 on) conditions.  There is a significant effect of lesion 
condition (control vs. VGlut2 gene deletion) on CI (our estimate for circadian amplitude, see methods) of 
locomotor activity for the LD and DD measures combined (p=0.001).   Univariate tests done on the LD 
and DD measures separately indicate that locomotor activity rhythm CI in mice with VGlut2 deletion from 
the DMH is significantly lower than in controls in both LD (p=0.001) and DD (p=0.001), see Fig. 3.2E, 
Table 3.1.  There is also a significant effect of lesion condition on average levels of locomotor activity over 
the whole (subjective) day, with pooled LD and DD data (p=0.013).  Univariate tests show these were 
significantly lower in mice with VGlut2 deletion from the DMH than controls in both LD (p=0.010) and DD 
(p=0.025), see Fig. 3.2F.  The CI of body temperature rhythms was not significantly affected by lesion 
condition, or its interaction with light cycle (p=0.088 and 0.711, respectively), see Fig. 3.2A, B, G.  There 
was, however a significant effect of lesion condition on body temperature average over the whole 
(subjective) day seen with combined LD and DD data (p=0.002). Univariate tests confirmed lowered body 
temperature (by about 0.2oC in LD and 0.3oC in DD) in mice with VGlut2 deletion in the DMH compared to 
controls in both LD (p=0.014) and DD (p=0.001). 
To investigate whether decreases in locomotor activity and body temperature occurred 
throughout the subjective day or were confined to the (subjective) light or dark period, linear mixed 
models were used to test for the effect of lesion condition, subjective light vs. dark, and the interaction of 
the two on locomotor activity (normalized to 100% of corresponding control animal levels to account for 
possible variation in factors affecting activity levels from one run of the experiment to the next) and body 
temperature (this variable was not normalized as it showed remarkable consistency across cohorts), see 
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Figure 3.2 Panels A-D: Raster plots (double plotted) showing body temperature (A, B) and locomotor 
activity (C, D) rhythms in a representative control mouse (A, C) and mouse with VGlut2 deletion in the 
DMH (B, D).  The first 10 days of the recordings shown are in a 12:12 light:dark cycle (LD), with dark grey 
bars on top indicating the dark phase, the remaining days below are in constant darkness (DD).  Panels 
E-H: Graphs showing circadian index (E, G) and daily averages (F, H) of locomotor activity (E, F) and 
body temperature (G, H). 
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Figure 3.2 (continued) 
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Table 3.1 Locomotor activity and body temperature averages for the subjective dark phase, subjective 
light phase, and whole subjective day, as well as circadian index, calculated in both entrained and free-
running conditions 
 
 AAV-GFP control VGlut2 deletion in DMH 
   
entrained (LD) locomotor activity   
daily average 100.00 ± 9.20% 71.01 ± 7.87%*  
light phase 100.00 ± 7.97% 94.09 ± 15.84% 
dark phase 100.00 ± 9.34% 60.85 ± 7.45%* 
circadian index 100.00 ± 10.26% 48.16 ± 10.47%*  
free-running (DD) locomotor activity   
daily average 100.00 ± 7.40% 73.96 ± 7.84%* 
 subjective light phase 100.00 ± 9.56% 93.52 ± 13.31% 
subjective dark phase 100.00 ± 10.95% 65.95 ± 7.00%* 
circadian index 100.00 ± 10.00% 47.62 ± 12.81%* 
entrained (LD) body temperature   
daily average 36.54 ±0.06 36.33 ±0.07 
light phase 35.96 ± 0.08 35.87 ± 0.12 
dark phase 37.09 ± 0.08 36.78 ± 0.05* 
circadian index 100.00 ± 6.81% 82.32 ±10.65% 
free-running (DD) body temperature   
daily average 36.62 ±0.05 36.33 ±0.07* 
 subjective light phase 36.15 ± 0.11 35.86 ± 0.11* 
subjective dark phase 37.09 ± 0.12 36.79 ±0.07* 
circadian index 100.00 ± 7.42% 88.54 ±10.96% 
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Fig. 3.3.  In mice entrained to the LD cycle, there was a significant effect of lesion condition (p=0.038), 
light v. dark phase (p=0.023) and the interaction between the two factors (p=0.023) on locomotor activity 
levels (with type III tests of fixed effects).  Univariate tests revealed a significant difference between 
activity levels in control mice and those with VGlut2 loss in the DMH in the dark phase (p=0.003) but not 
in the light phase (p=0.631).  In free-running mice, type III tests of fixed effects  revealed a significant 
effect of both lesion condition (p=0.047) and the interaction between lesion condition and subjective light 
v. dark phase (p=0.099) on locomotor activity levels.  Univariate tests again showed a significant 
difference between activity levels in control mice and those with VGlut2 loss in the DMH in the dark phase 
(p=0.009) but not in the light phase (p=0.605).  Taken together, these results indicate that the decrease in 
locomotor activity levels over the whole subjective day seen in mice with VGlut2 loss in the DMH is 
attributable exclusively to a decrease in activity levels during the (subjective) dark phase, and that this 
decrease also accounts for the drop in CI of activity rhythms observed.  A very similar pattern was seen 
when these tests were performed for body temperature in mice entrained to the LD cycle.  There was a 
significant effect of lesion condition (p=0.024), light v. dark phase (p<0.000) and the interaction between 
the two factors (p=0.071) on average body temperature readings seen with type II tests of fixed effects.  
Body temperature was significantly lower in mice with VGlut2 loss in the DMH than in controls in the dark 
phase (p=0.004) but not the light phase (p=0.337).  However, in free-running mice, the interaction 
between lesion condition and subjective light v. dark phase had no significant influence on body 
temperature (p=0.915), whereas lesion condition (p=0.024) and subjective light v. dark phase (p<0.000) 
did on their own.  In free-running conditions, mice with VGlut2 expression loss in the DMH had 
significantly lower average body temperature readings both during the subjective dark phase (p=0.023) 
and the subjective light phase (p=0.023) relative to controls.  A further type III test was run to ensure that 
the effect of the interaction between lesion condition and light cycle on (subjective) daytime body 
temperature was significant, and this proved to be the case (p=0.095).  Univariate tests following this 
analysis confirmed that (subjective) light phase body temperature is significantly lower in mice with VGlut2 
loss in the DMH than in controls under free-running (DD) conditions (p=0.025) but not under light-
entrained (LD) conditions (p=0.427).  It is worth noting that there was no significant difference between 
LD light phase body temperature and DD subjective light phase body temperature of mice with VGlut2  
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Figure 3.3 Phase plots showing body temperature (A) and locomotor activity (B) rhythms averaged for 
n=7 mice with loss of VGlut2 in the DMH and n=9 controls that were all recorded in the same cohort, 
accompanied by plots showing average body temperature (C, E) and average locomotor activity counts 
normalized to controls (D, F) during the (subjective) light and dark phase in both entrained (LD) (panels 
C, D) and free-running (DD) (panels E, F) conditions, for n=9 mice with loss of VGlut2 in the DMH and 
n=13 controls (all mice with reliable body temperature recordings). 
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deletion in the DMH (p=0.960).  However, light phase body temperature in entrained control mice was 
significantly lower than subjective light phase body temperature in free-running control mice (p=0.014) 
suggesting that light is unable to lower body temperature in mice with VGlut2 loss in the DMH the way it 
does in controls. 
To determine whether injection of the AAV-GFP-ires-Cre vector itself could account for these 
findings, we examined wildtype animals receiving this vector before and after the injection.  Paired t-tests 
showed no significant change in average locomotor activity (p=0.909), its CI (p=0.991), average body 
temperature (p=0.263), or its CI (p=0.142) (n=6) (see Table 3.2), indicating that transduction by the viral 
vector alone does not explain these findings, but that the effects are due to the excision of the second 
exon of the VGlut2 gene by Cre recombinase in DMH neurons.  To determine whether the lower activity 
levels in the animals with DMH deletions was due to motor impairment, we also measured their ability to 
maintain their balance on a rotating rod  There was also no significant change in performance on thise 
test between controls (n=7) 208.02 ± 25.63 sec. and mice with VGlut2 deletion from the DMH (n=4) 
162.04 ± 24.46 sec., (p = 0.310), suggesting that the decrease in locomotor activity levels seen with loss 
of VGlut2 in the DMH is not secondary to a deficit in mobility or motor control.   
 
Loss of VGlut2 expression in the DMH does not significantly affect rhythms or total daily levels of 
liquid diet intake 
Plots of liquid diet intake rhythms under entrained (see Fig. 3.4A, C, D) and free running (see Fig. 
3.4B, C, D) conditions suggest there is no difference in total daily liquid diet intake between control mice 
and mice with VGlut2 deletion in the DMH (in either light cycle).  This was confirmed by a linear mixed 
models analysis.  Mice with VGlut2 loss in the DMH showed a trend toward a decrease in the CI of their 
liquid diet intake rhythm under free-running (but not under entrained) conditions, but this effect was not 
statistically significant ( effect of interaction between lesion condition and light cycle on CI of liquid diet 
intake rhythm p=0.182, type III test of fixed effects). 
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Table 3.2 Circadian index and average daily locomotor activity and body temperature in wild type control 
mice before and after injections of Cre-expressing vector (AAV-GFP-ires-Cre) into their DMH 
 
 
 WT control pre-Cre WT control post-Cre 
 
free-running (DD) locomotor activity 
 
  
average for whole subjective day 
(raw counts)
4.90 ± 0.75 4.93 ± 0.78 
  
average for whole subjective day 
(expressed as % pre-Cre average)
100.00 ± 15.39% 100.53 ± 15.92% 
  
circadian index 100.00 ± 19.48% 99.87 ± 12.44% 
  
free-running (DD) body temperature 
 
  
average for whole subjective day 36.47 ± 0.08 36.43 ± 0.05 
  
circadian index 100.00 ± 11.95% 110.21 ± 9.33% 
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Figure 3.4 Phase plots showing liquid diet intake volumes (A, B) and urinary corticosterone amounts (E, 
F) measured at each of six time points in both entrained (LD) (panels A, E) and free-running (DD) (panels 
B, F) conditions, along with graphs showing circadian index (C,G) and daily averages (D, H) of liquid diet 
intake volumes (C, D) and urinary corticosterone amounts (G, H).
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Loss of VGlut2 expression in the DMH blunts circadian but not diurnal rhythms in urinary 
corticosterone 
Prior to analysis of rhythms in urinary corticosterone, we tested for potential significant effects of 
VGlut2 deletion in the DMH, light cycle, or their interaction on urine output volumes or the CI of urine 
output volumes and found none.  We also tested for effects of the above factors on the total daily amount 
of corticosterone excreted in the urine and found a significant effect of interaction between lesion 
condition and light cycle on this parameter (p=0.065).  However, univariate tests showed no significant 
difference between total daily urinary corticosterone amount in control mice and mice with loss of VGlut2 
in the DMH under light-cycle entrained conditions (p=0.827), and fell just short of significance under free-
running conditions (p=0.053).  Testing for the effect of the same factors on the CI of urinary 
corticosterone, we also found a significant effect of the interaction between lesion condition and light 
cycle on this parameter (p=0.049).  The CI of urinary corticosterone was significantly decreased in free-
running mice with VGlut2 loss in the DMH compared to free-running controls (p=0.012), but there was no 
significant difference between these two groups under light-cycle entrained conditions (p=0.805). 
 
Discussion 
In this study, we selectively deleted the expression of VGlut2 from neurons in the DMH, to study 
the role of glutamatergic DMH neurons in organizing circadian rhythms.  Loss of  
VGlut2 from DMH neurons produced phenotypes similar to the nonspecific lesions of DMH neurons, with 
respect to locomotor activity and body temperature.  The circadian index of locomotor activity was 
decreased, as was the overall level of locomotor activity, while the circadian index of body temperature 
was unaffected, but the mean body temperature was lowered by approximately 0.2-0.3oC relative to 
controls. Deleting glutamatergic transmission from DMH neurons also reduced the circadian index of 
corticosteroid secretion, although this effect was not as great as when DMH neurons were non-selectively 
killed. On the other hand, unlike nonspecific lesions, which almost eliminated the circadian rhythms of 
food intake, we found that deletion of VGlut2 expression from DMH neurons did not significantly affect 
this function. 
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Technical considerations  
To delete the second exon of the VGlut2 gene in DMH neurons, we stereotaxically injected 
adeno-associated viral vectors expressing Cre recombinase.  To ensure that any effects seen were not a 
result of transduction with viral vectors in our VGlut2 flox/flox mice, controls for these experiments were 
VGlut2 flox/flox mice injected with AAVs that expressed only GFP.  We also controlled for the possibility that 
Cre-expression on its own could affect function of neurons in the DMH, by injecting Cre-expressing 
vectors into wildtype mice as well, and saw no resultant effects on locomotor activity or body temperature.  
Because it is difficult to make symmetric injections of AAVs that involve the bulk of the targeted structure, 
we first examined the histology in our animals, and chose cases in which the deletions included the bulk 
of the DMH bilaterally, avoiding any cases with robust bilateral hits to other nearby structures.   
Because the AAV-Cre vector expresses Cre recombinase at a higher level than the AAV-GFP-
ires-Cre vector, but only one molecule of Cre is required for recombination to occur, we could not 
compare the completeness of the deletion by counting the absolute number of Cre-immunoreactive 
neurons, which was low and variable in the animals injected with AAV-GFP-ires-Cre.  (In many Cre-
expressor mouse lines, the levels of Cre expression are too low to stain them immunohistochemically at 
all, yet crosses with reporter lines demonstrate extensive Cre recombination.)  Because Cre 
immunolabeling was not an effective way to reveal the spatial extent of viral infection in our cases with 
AAV-GFP-ires-Cre, immunolabeling for GFP was performed instead.  While staining for Cre in AAV-Cre-
injected mouse brains labels only transduced cell nuclei in a clearly distinguishable way (see Fig. 3.1 A-
C), staining for GFP in AAV-GFP-ires-Cre-injected mouse brains labeled cell bodies and processes 
creating much more spatial overlap of labeled structures, and making it more difficult to distinguish 
individual GFP-labeled neurons from each other and from the plexus of labeled axonal/dendritic fibers 
surrounding them (see Fig. 3.1 D-F), resulting in probable undercounting of transduced DMH neurons.  
To compensate for these differences in quantification of the number of transduced neurons across the 
two cohorts, we relied on spatial mapping of the percent of the DMH (or DMH/DHA) covered by the 
injection sites as a quantitative measure.   
We selected the two DMH levels (AP -1.7 and -1.9)  based on the level at which cell-specific 
lesions in the DMH had strongest effects on activity and corticosterone and the levels at which cells 
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projecting to the LHA and VLPO are concentrated, as determined by retrograde tracing from these two 
DMH targets (Chou et al., 2003).  The DMH/DHA subregion used corresponds to the subregion projecting 
robustly to the RPa, determined by retrograde tracing from the RPa (Yoshida et al., 2009). 
Both of these viral vectors have previously been shown to reliably and effectively excise exon 2 of 
the VGlut2 gene in transduced VGlut2-expressing neurons of VGlut2 flox/flox mice both via in situ 
hybridization for VGlut2 exon 2 and by immunostaining for VGlut2 protein in synaptic terminals of 
transduced neurons (Krenzer et al., 2011; Kaur et al., 2013).  Electrophysiological recordings on autapses 
cultured from VGlut2 flox/flox mice also demonstrate that Cre-expressing neurons from these animals do not 
show glutamatergic excitatory post-synaptic currents in vitro (i.e. no excitatory post-synaptic currents that 
could be recorded from Cre-positive neurons are blocked by glutamate receptor antagonists) (Tong et al., 
2007).  Tong and colleagues also showed that VGlut2 flox/flox mice crossed to a Cre-expressing line fail to 
show an increase immediate early gene expression in synaptic targets of the Cre-expressing neurons 
after stimuli known to drive the Cre-positive cells. 
 
Glutamatergic neurotransmission by DMH neurons is necessary for reaching normal levels of 
locomotor activity during the (subjective) dark phase 
VGlut2 deletion in the DMH decreased the amplitude of locomotor activity rhythm to roughly half 
that of controls in both free-running and entrained conditions.  This came from a significant drop in 
(subjective) night-time (i.e. dark phase) activity levels, as there was no significant change to (subjective) 
daytime (i.e. light phase) activity amounts.   In both free-running and entrained conditions, the average 
daily locomotor activity was reduced to approximately 75% of that seen in controls.  Since mice with these 
genetic deletions did not show impaired performance on a rotarod task, we believe the decreased 
nocturnal activity was not secondary to any kind of motor outflow impairment, but may be related to 
changes in motivation, wakefulness, consolidation of wakefulness, or some interaction thereof.   
By comparison, cell-specific lesions in the DMH lower the amplitude of locomotor activity rhythms 
to approximately 10% that of controls and decrease total daily locomotor activity levels to roughly one 
third of levels seen in controls (Chou et al., 2003).  Activity counts are lowered both during the subjective 
light and dark phase, though there is a larger decrease for the subjective dark phase.   
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Taken together this suggests that glutamatergic neurotransmission in DMH neurons is certainly 
involved in driving activity rhythms during the dark phase, but cannot account for the full role of the DMH 
in determining the amount of locomotor activity over the course of the day on its own.  It appears most 
likely that non-glutamatergic DMH efferents (such as its GABAergic projection to the VLPO) are also 
critically involved in driving normal daily patterns in locomotor activity.  That said it is possible that 
differences in the effect of cell specific lesions vs. VGlut2 deletions on activity levels across the day are 
also in part accounted for by species differences between rats and mice, and/or that we saw milder 
effects with VGlut2 deletions because they involved a smaller fraction of DMH neurons than excitotoic 
lesions. 
 
Glutamatergic neurotransmission by DMH/DHA neurons is necessary for maintenance of normal 
core body temperature throughout the day 
Loss of VGlut2 expression in our experiments decreased core body temperature by 
approximately 0.3ºC, thus lowering it to the same extent as complete cell-specific DMH lesions in rat 
(Chou et al., 2003).  Hence it is likely that the effect of the neurons in the DMH region on supporting 
baseline core body temperature is chiefly, if not completely, dependent on its glutamatergic efferents. 
Studies in rats have shown that a specialized population of glutamatergic neurons, in the DMH/DHA 
along the dorsal border of the DMH, has direct projections to the raphe pallidus nucleus.  The raphe 
pallidus innervates sympathetic preganglionic neurons in the spinal cord that drive brown adipose tissue 
thermogenesis and cutaneous vasoconstriction that conserves heat (Zaretskaia et al., 2003; Zaretsky et 
al., 2003a; Zaretsky et al., 2003b).  Thus the input from the DMH/DHA to the raphe pallidus is likely to 
play a major role in maintaining Tb.  
Conditional tracing using injections of a viral vector with a loxP-flanked stop codon upstream of 
the GFP gene (Gautron et al., 2010) into a VGlut2-Cre mouse line (Vong et al., 2011) reveals a robust 
glutamatergic projection from the DMH/DA to RPa (Vujovic, unpublished results).  Furthermore we 
observe GFP-labeled fibers in the RPa in AAV-GFP-ires-Cre-injected VGlut2flox/flox mice showing a 
decreased body temperature. 
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  The decrease seen in body temperature may also to some extent be secondary to the decrease 
in locomotor activity seen with this manipulation, however, this cannot account for the full magnitude of 
the effect.  The selective decrease in activity levels during the subjective (and objective) dark phase 
accounts for both the reduction in total daily activity counts and the amplitude of activity rhythms, whereas 
there is no significant reduction in the amplitude of body temperature rhythms.  Furthermore, during the 
subjective light period in free-running conditions, we saw a significant decrease in body temperature but 
not locomotor activity of mice with VGlut2 loss in the DMH relative to controls. 
 The fact that body temperature in mice with VGlut2 loss in the DMH is equally low in the 
subjective light phase during free running conditions and the objective light phase of entrained conditions, 
whereas control mice show a lowered temperature in objective light, suggests that VGlut2 loss in the 
DMH also prevents normal lowering of body temperature in response to light.   
 
Glutamatergic neurotransmission in DMH neurons is necessary for normal circadian rhythms in 
corticosterone excretion 
Deletion of VGlut2 from the DMH causes a change in the circadian but not diurnal rhythm in 
corticosterone excretion.  In free-running conditions, the amplitude of the circadian rhythm of 
corticosterone excretion is lowered to roughly half that seen in controls.  In this, VGlut2 deletion 
resembles the effects of complete excitotoxic (Chou et al., 2003) or electrolytic (Bellinger et al., 1976) 
DMH lesions in rat, which dramatically lower the amplitude of circadian rhythms in corticosteroids.  
However, with complete DMH lesions in the rat, this decrease in amplitude comes from a reduction in 
corticosteroid levels during the subjective dark phase (the phase during which they peak in controls), 
whereas in mice with VGlut2 deletion in the DMH the peak is retained and it is the trough that appears 
altered.  While complete DMH lesions in rat lower average daily plasma corticosteroid levels nearly in 
half, deletion of VGlut2 in the DMH of mice does not cause a significant decrease in daily corticosterone 
levels.  There is instead an upward trend in total corticosterone levels excreted over the course of a day 
in free-running conditions, which falls just short of reaching statistical significance (p=0.053, see results).  
Thus while glutamatergic neurons in the DMH do appear involved in mediating normal circadian 
oscillation in corticosterone, there may be other cell groups playing equally important roles.   
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However, several important caveats must factor into a comparison between the results reported 
here and those found following excitotoxic lesions of the DMH in rat.  Not only were the studies performed 
on two different species, but they also used two different techniques to measure two different indicators of 
corticosteroid levels in the body.  Chou et al. report levels of corticosteroids in blood plasma, sampled 
throughout the day with the aid of an indwelling intravenous catheter.  We measured amounts of 
corticosterone in urine sampled throughout the day with the aid of metabolic cages.  The peak of urinary 
corticosterone lags that of plasma corticosterone by several hours.  Levels of plasma corticosteroids can 
be influenced by the hypothalamo-pituitary adrenal axis, sympathetic input to the adrenal gland and the 
molecular clock in the adrenal gland, as well as interaction of three (please see Chapter 1 “How does the 
circadian timing system communicate with brain regions regulating autonomic and neuroendocrine 
functions?”).  In addition, levels of urinary corticosteroids can be influenced by factors affecting the rate at 
which corticosteroids are metabolized or filtered into urine, including circadian clocks in the kidney and 
liver, sympathetic or parasympathetic input to these organs, or any other factor that can influence renal 
and hepatic handling of glucocorticoids.   
The above considerations make pinpointing the neural pathway by which glutamatergic neurons 
in the DMH influence corticosteroid rhythms extremely difficult, although there are certain possibilities that 
can be eliminated.  The significant decrease in the amplitude of circadian rhythms of corticosterone 
observed in mice with VGlut2 gene loss in the DMH is unlikely to depend on a direct glutamatergic 
projection from the DMH to corticotropin-releasing hormone (CRH) neurons in the parvicellular PVH.  
CRH neurons actively drive corticosterone production and release from the adrenal gland, hence, it is to 
be expected that withdrawing direct excitatory input to them would lead to a decrease (not an increase) in 
plasma and urine levels of corticosteroids.  The observed effect could be caused by an indirect 
(multisynaptic) projection in to CRH neurons, which would have a net inhibitory effect on them, and 
normally function to suppress corticosterone production during the subjective day.  It is also possible that 
glutamatergic projections from the DMH modulate renal, adrenal or hepatic sympathetic nerve input in a 
way that would alter levels of corticosterone excreted in the urine at various times of day.  Finally, 
peripheral molecular clocks in the adrenal gland have been shown to influence rates of glucocorticoid 
release into central circulation (Son et al., 2011; Ota et al., 2012) and the amplitude and synchrony of 
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their oscillations could be affected by a number of factors, notably by timing of food intake or locomotor 
activity, that may depend on the DMH. 
 
Glutamatergic neurotransmission in DMH neurons is not critical for circadian or diurnal rhythms 
in nutrient intake 
 Unlike rats with excitotoxic (Chou et al., 2003) or electrolytic (Bernardis, 1973; Bellinger et al., 
1976) lesions in the DMH, which showed a dramatic reduction in the amplitude of circadian rhythms in 
feeding, mice with VGlut2 loss in the DMH did not show a consistent reduction in circadian rhythms of 
nutrient intake (see Fig. 3.4B, C).  Importantly, in addition to species differences between these 
experiments, there was also a critical methodological difference: the mice were sustained on a liquid diet 
during the experiment measuring caloric intake across the day, to some extent conflating the feeding and 
drinking rhythms, while the rats were simply fed a chow diet, so a comparison is not straightforward.  In 
our study, the use of liquid diet was necessary for two reasons: (a) mice on chow diet did not excrete a 
high enough urine volume at a high enough frequency to allow for measurement of urinary corticosterone 
at six time points and (b) because mice consume very small volumes of solid food or water in a 4-hour 
time interval, sustaining them on a liquid diet meant each mouse consumed a larger volume between 
each of the six time points and provided a means to quantify the amount of nutrients consumed at 
different times of day with reduced measurement error.    
It is certainly possible that deletion of VGlut2 in the DMH does not significantly lower the 
amplitude of nutrient intake in mice because other, DMH neurotransmitters are responsible for driving this 
rhythm.  However, it is also possible that glutamatergic neurons in the DMH are involved in circadian 
regulation of food intake but that this experiment was not sufficiently powered in terms of animal numbers 
to reveal this effect. 
 
Light cycle effects on body temperature and corticosterone excretion rhythms 
The light cycle significantly affects the difference between control animals and those with VGlut2 
loss from the DMH with respect to their daytime body temperature and the amplitude of their 
corticosterone rhythm.  Mice with VGlut2 deletion in the DMH only show a lowered daytime body 
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temperature and lower amplitude corticosterone excretion rhythm (relative to controls) in free-running 
conditions.   
 In the case of body temperature, this difference appears to be caused a by a reduction of daytime 
(i.e. light phase) temperature in entrained as opposed to free-running control mice, as there is no 
significant difference in daytime temperature between free-running and entrained mice with loss of  
VGlut2 in the DMH.  This is consistent with previous reports in the literature of light acutely lowering body 
temperature in nocturnal rodents (Morin, 2013; Muindi et al., 2013; Studholme et al., 2013).  The fact that 
light does not seem to have this effect in mice with VGlut2 deletion in the DMH suggests either that acute 
effects of light on body temperature are dependent on glutamatergic signaling from the DMH (i.e. happen 
upstream of or at the level of the DMH in the context of outflow circuitry), or that the genetic lesion creates 
a floor effect on baseline temperature, where light cannot suppress it further without activating 
homeostatic systems which keep it no lower than 35.8±0.15ºC. 
 In the case of corticosterone excretion rhythms, the difference seems to be accounted for by an 
increased daytime corticosterone excretion in free-running compared to entrained mice with VGlut2 
deletion from the DMH.  This suggests that light could act to lower daytime corticosterone production or 
release in LD-entrained mice with VGlut2 loss in the DMH.  It thus suggests that (direct or indirect) input 
from the retina must act on structures affecting corticosterone release which are further downstream in 
the outflow circuit than excitatory neurons in the DMH.  However, light effects on urinary corticosterone 
levels in these mice may not be, and indeed do not seem to be the same as acute light effects on 
corticosterone in intact rodents (Ishida et al., 2005; Mohawk et al., 2007). 
 
Conclusions 
Taken together, the results of selective VGlut2 deletion from the DMH suggest that glutamatergic 
neurotransmission from DMH neurons may be single-handedly responsible for its role in 
thermoregulation, and may be necessary for normal lowering of body temperature in response to light.  
Together with other neurotransmitters in the DMH, glutamate in this region plays a significant role in 
establishment of circadian and diurnal rhythms in locomotor activity and maintenance of normal daily 
activity levels.  Glutamatergic DMH neurons seem to impact urinary corticosterone levels in a light-
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dependent manner, such that loss of VGut2 in the DMH blunts free-running but not entrained rhythms of 
urinary corticosterone. 
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Chapter 4: Conclusions and future directions 
 
The work described here focuses on elucidating neural circuits that drive circadian and diurnal 
rhythms in behavior and physiology in mammals and keep these functions synchronized.  As described in 
Chapter 1, there is evidence that disruption of the synchrony between these functions can substantially 
impair sleep quality, diminish cognitive performance, and be a risk factor for mental health/affect 
disorders, hypertension, diabetes and metabolic deficits, cancer, and significantly elevated mortality rate. 
The main pacemaker in mammals that drives and synchronizes these rhythms is the SCN.  This 
nucleus has robust circadian molecular oscillators in every neuron, which are well-coupled to each other. 
The SCN also shows daily patterns in neuronal firing rate and (in younger animals) in the release of 
paracrine signaling factors, and relies on such outputs to communicate timing signals to the rest of the 
brain and body. 
 Several lines of evidence reveal the importance of neural efferents from the SCN in driving 
circadian rhythms throughout the body at their maximum amplitude (see Chapter 1).  SCN transplants 
cannot restore systemic rhythms to their full amplitude, and cannot restore certain kinds of rhythms at all. 
Lesions to SCN efferent targets and/or knife cuts between the SCN and its efferent targets result in 
severe disruption of many circadian rhythms.  In particular, lesion studies show that the SPZ and DMH 
are both critical for normal expression of circadian rhythms in activity, sleep-wake, and body temperature, 
and in the case of the DMH also corticosteroid release and feeding.  These two structures both receive 
input from the SCN: robust direct neural input in the case of the SPZ and more sparse direct input 
coupled with indirect (multisynaptic) input via the SPZ in the case of the DMH.  Thus, they are thought to 
act as relay nuclei in the outflow circuit by which the SCN communicates with the rest of the brain and 
body.  The experimental work presented in chapters 2 and 3 furthers our understanding of how the SPZ 
and DMH, respectively, act to relay signals from the SCN to the rest of the brain and body, and how they 
may integrate non-circadian inputs and outputs into this neural circuit. 
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Connectivity of the subparaventricular zone and its subdivisions: findings and future directions 
The SPZ is mainly GABA-ergic and cytoarchitecturally indistinguishable from the neighboring 
AHA.  It is chiefly defined as the area dorsal to the SCN, receiving a dense input from the SCN.  That 
said, the inputs received by the medial vs. lateral SPZ differ, with the medial SPZ receiving more input 
from AVP-ergic neurons in the SCN shell, and the lateral SPZ receiving more input from the SCN’s VIP-
ergic core as well as from the retina.  Furthermore, the physiological functions of the dorsal vs. ventral 
SPZ seem to be different as well, with the dorsal subdivision implicated in the regulation of rhythms in 
body temperature and the ventral in regulation of locomotor activity and sleep-wake rhythms.  This 
suggests that there may be four relevant SPZ subdivisions.  As described in Chapter 2, we studied the 
efferents of the four SPZ subdivisions and of the SPZ as a whole and made several significant 
observations.  First, in addition to its previously reported efferent targets, the SPZ also innervates the 
dorsal raphe, locus coeruleus, pre-coeruleus region, lateral parabrachial nucleus and Barrington’s 
nucleus, which may play a role in circadian modulation of behavioral state.  We also observed that the 
four SPZ subdivisions project to each other and to the suprachiasmatic nucleus.  This connectivity allows 
for local circuits to share information within the SPZ and suggests circadian outflow through it could be 
considerably more complex than previously described.  Finally the four SPZ subdivisions, dorsomedial 
(dmSPZ), ventromedial (vmSPZ), dorsolateral (dlSPZ), and ventrolateral (vlSPZ), differ slightly in the 
density of their inputs to certain targets, as summarized in Fig. 3.1.  Taken together with differences in 
their inputs, this suggests the four SPZ subdivisions may have functionally distinct roles (See Fig. 4.1). 
 The functional consequences of these differences in anatomical connectivity remain to be tested.  
For instance, though it is implicated in determining diurnal vs. nocturnal preference in developing rodents, 
does the vlSPZ play a role in light entrainment in adult animals or in mediating acute effects of light on 
downstream measures?  Does it perhaps only do so in animals with a damaged or non-functional SCN?   
Given its projections to the IGL and PVT, is the vlSPZ involved in non-photic entrainment?  Does the 
remarkably robust projection from the dlSPZ to the VMH mediate rhythms of feeding, metabolic 
regulation, or aggression?  Given its efferents to the AVPe, is the vmSPZ necessary for normal rhythms in 
leutenizing hormone in females?  Testing the above questions by lesioning, stimulating or inhibiting the  
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 Figure 4.1 Diagram summarizing inputs to the four different SPZ subregions [dorsomedial (dmSPZ), 
ventromedial (vmSPZ), dorsolateral (dlSPZ) and ventrolateral (vlSPZ)], the targets preferentially innervated 
by each subdivision, and the functional role this may suggest for each subdivision (based on data from 
Chapter 2). 
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Figure 4.1 (continued) 
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four SPZ subdivisions would yield valuable information on how outflow from the clock drives circadian 
patterns. 
There are a number of relatively new methodologies which could facilitate testing these 
hypotheses in a functional manner in the future.  For example, using genetic markers such as receptors 
for pituitary adenylate cyclase activating peptide (PACAP), which is co-released with glutamate by retinal 
fibers innervating the SPZ, could potentially help restrict a lesion to the vlSPZ.  Similarly, expression of 
receptors for arginine vasopressin (AVP) a neurotransmitter expressed in the SCNshell, which 
preferentially innervates the medial SPZ, could be exploited to achieve a more selective lesion of the 
vmSPZ and dmSPZ.   
There is also an interesting consideration of the overall circuit that could explain the function of 
intra-SPZ projections.  SCN lesions, SPZ lesions and DMH lesions all blunt the amplitude of rhythms in 
activity/wake in nocturnal rodents by decreasing overall levels throughout the day.  There is evidence to 
suggest that the main SCN output to the SPZ would be inhibitory, as would SPZ input to the DMH.  If this 
rhythm really does depend on two inhibitory projections, one could expect that disruption of the circuit at 
the level of the SPZ would lead to increased activity/wakefulness (since this lesion would be disinhibiting 
downstream neurons in the DMH and elsewhere that drive wakefulness and activity).  However, the 
opposite is true, but could easily be explained by acknowledging the presence of an extra inhibitory 
synapse in the SPZ as part of the circuit (see Fig. 4.2).  It is important to remember that provides 
excitatory retinal input to the SCN, vlSPZ, and many other sites in the brain simultaneously, and the 
circuits proposed in fig. 4.2 are only predictive in a free-running or stably entrained context (as opposed to 
a phase-shifting and/or light masking situation).  Much work remains to be done be done before we truly 
understand the neural circuits mediating the acute effects of light on physiology. 
 
The role of excitatory DMH neurons in circadian and homeostatic regulation: findings and future 
directions 
The DMH is a considerably more heterogeneous nucleus than the SPZ, having both 
cytoarchitecturally and neurochemically defined subdivisions.  We chose to test the role of glutamatergic  
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Figure 4.2 Schematic diagrams illustrating (A) rhythms of  immediate early gene activity and presumably 
also maximum neuronal firing in the SCN and vSPZ of nocturnal vs diurnal rodents: in nocturnal rodents, 
both the SCN and vSPZ fire most during the (subjective) light phase, in alignment with each other, but in 
diurnal rodents they appear to be in antiphase patterns [with the SCN peak still during (subjective) light, but 
the vSPZ peak occurring during the (subjective) dark].  (B) schematic depiction of how a neural circuit with 
only one synaptic contact going from the SCN to SPZ and SPZ to DMH gives rise to diurnal behavior (C) and 
how adding an intra-SPZ connection would instead give rise to nocturnal behavior. 
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efferents from this nucleus in part because of their largely accepted role in thermoregulation (i.e. 
projection to RPa) and hypothesized role in wake consolidation (i.e. projection to LHA).     
 We found that selective loss of glutamatergic signaling was enough to disrupt many of the 
physiological outputs disrupted by whole DMH lesions.  The amplitude of the circadian rhythm in 
locomotor activity was significantly decreased, as were average activity levels over the course of the 
whole subjective day, but neither was decreased to the same extent seen with cell-specific DMH lesions.  
The amplitude of circadian rhythms in corticosteroid release is also reduced by loss of VGlut2 
expression in the DMH, but again to a lesser extent than by cell-specific DMH lesions.  Loss of VGlut2 
expression in the DMH lowered the baseline body temperature by approximately the same amount as 
excitotoxic DMH lesions. 
It is not yet clear whether the above results were obtained because glutamatergic signaling from 
the DMH is necessary and sufficient to drive the effects of this nucleus on body temperature, but other 
neurotransmitters are involved in mediating DMH effects on activity and corticosteroid release.  This 
interpretation is highly consistent with the literature. However, the results may also be explained by 
differences in lesion extent.  In the experiment reported in Chapter 3, there was on average 90% 
DMH/DHA coverage per side for the mice in which body temperature was successfully measured, 77% 
coverage per side of the relevant DMH levels for mice with successful locomotor activity recordings, and 
72% DMH coverage per side for mice in which reliable, phase-aligned corticosterone output data was 
available. 
This leaves open the question of which other neurotransmitters in the DMH may play a significant 
role in the regulation of activity and corticosteroid rhythms.  Histological evidence implicates GABA (see 
Chapter 1), a hypothesis testable by using conditional knockout mice to prevent release of this 
neurotransmitter from DMH neurons. The role of many other neurotransmitter candidates can be studied 
using methods similar to those described in Chapter 3. 
Although previous work (see Chapter 1) suggests that the DMH sends a predominantly 
glutamatergic projection to LHA and predominantly GABAergic projection to VLPO, it also suggests that 
neither VLPO lesions nor LHA lesions reduce the amplitude of circadian rhythms in activity (and probably 
wakefulness) to the extent that DMH lesions do, or even to the extent that VGlut2 deletion in this region 
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does.  Are there other projections from the DMH, perhaps to other sleep or wake promoting regions in the 
brain that are also involved?   Conditional tracing studies from genetically defined subpopulations of DMH 
neurons could begin to answer this question.  In the case of body temperature regulation, both previous 
literature and unpublished conditional tracing experiments from our own lab (using a Cre-driven tracer 
injected into the DMH VGlut2-Cre mice) strongly implicate a glutamatergic projection from the DMH to the 
raphe pallidus. 
Finally, it bears mention that, in vivo, many of the parameters we typically attempt to study 
independently may interact with each other.  There are well documented interactions between sleep, 
activity, circulating corticosteroids and body temperature (see Chapter 3).  Can we clarify which of these 
functions are perturbed secondarily to disruption of another function?  Can extrinsically driving one 
rhythm, perhaps via light-cycle or feeding schedule, restore other, secondary rhythms, even in an animal 
or person with circadian disruption?  The fact that mice with VGlut2 loss in the DMH show normal urinary 
corticosterone rhythms in a 12:12 light:dark cycle, even though they do not under free-running conditions 
(see Chapter 3), is encouraging  in that regard.  We have much to learn from doing physiological 
experiments in both free-running and entrained conditions in tandem. 
